{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "import pyteomics.mgf\n",
    "from tqdm.notebook import tqdm\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "# infile = r\"C:\\git\\msn_library\\data\\gnpslib\\small_gnps.mgf\"\n",
    "# infile = r\"C:\\git\\msn_library\\data\\gnpslib\\ALL_GNPS_NO_PROPOGATED.mgf\"\n",
    "infile = r\"C:\\git\\msn_library\\library\\mce_msn_library_final.mgf\""
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "outputs": [
    {
     "data": {
      "text/plain": "0it [00:00, ?it/s]",
      "application/vnd.jupyter.widget-view+json": {
       "version_major": 2,
       "version_minor": 0,
       "model_id": "b12e02dd52564ec79b7f781abbe515ca"
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": "                name                      description   exactmass  \\\n0       pinometostat  MCE bioactive compounds library  562.337987   \n1       pinometostat  MCE bioactive compounds library  562.337987   \n2       pinometostat  MCE bioactive compounds library  562.337987   \n3       pinometostat  MCE bioactive compounds library  562.337987   \n4       pinometostat  MCE bioactive compounds library  562.337987   \n...              ...                              ...         ...   \n443825     Gefitinib  MCE bioactive compounds library  446.152097   \n443826     Gefitinib  MCE bioactive compounds library  446.152097   \n443827     Gefitinib  MCE bioactive compounds library  446.152097   \n443828     Gefitinib  MCE bioactive compounds library  446.152097   \n443829     Gefitinib  MCE bioactive compounds library  446.152097   \n\n              formula                                              inchi  \\\n0          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n1          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n2          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n3          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n4          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n...               ...                                                ...   \n443825  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443826  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443827  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443828  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443829  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n\n                           inchiaux  \\\n0       LXFOLMYKSYSZQS-LURJZOHASA-N   \n1       LXFOLMYKSYSZQS-LURJZOHASA-N   \n2       LXFOLMYKSYSZQS-LURJZOHASA-N   \n3       LXFOLMYKSYSZQS-LURJZOHASA-N   \n4       LXFOLMYKSYSZQS-LURJZOHASA-N   \n...                             ...   \n443825  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443826  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443827  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443828  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443829  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n\n                                                   smiles mslevel         rt  \\\n0       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n1       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n2       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n3       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n4       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n...                                                   ...     ...        ...   \n443825   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443826   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443827   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443828   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443829   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n\n       precursor_type  ... fragmentation_method isolation_window  \\\n0            [M+2H]2+  ...                  NaN              NaN   \n1            [M+2H]2+  ...                  NaN              NaN   \n2            [M+2H]2+  ...                  NaN              NaN   \n3            [M+2H]2+  ...                  NaN              NaN   \n4            [M+2H]2+  ...                  NaN              NaN   \n...               ...  ...                  ...              ...   \n443825         [M+H]+  ...                  NaN              NaN   \n443826         [M+H]+  ...                  NaN              NaN   \n443827         [M+H]+  ...                  NaN              NaN   \n443828         [M+H]+  ...                  NaN              NaN   \n443829         [M+H]+  ...                  NaN              NaN   \n\n       msn_collision_energies  \\\n0                         NaN   \n1                         NaN   \n2                         NaN   \n3                         NaN   \n4                         NaN   \n...                       ...   \n443825           [30.0, 40.0]   \n443826           [30.0, 20.0]   \n443827                    NaN   \n443828     [30.0, 40.0, 40.0]   \n443829     [30.0, 40.0, 20.0]   \n\n                                        msn_precursor_mzs  \\\n0                                                     NaN   \n1                                                     NaN   \n2                                                     NaN   \n3                                                     NaN   \n4                                                     NaN   \n...                                                   ...   \n443825               [447.159820556641, 128.106857299805]   \n443826               [447.159820556641, 128.106857299805]   \n443827                                                NaN   \n443828  [447.159820556641, 128.106857299805, 100.07565...   \n443829  [447.159820556641, 128.106857299805, 100.07565...   \n\n       msn_fragmentation_methods                      msn_isolation_windows  \\\n0                            NaN                                        NaN   \n1                            NaN                                        NaN   \n2                            NaN                                        NaN   \n3                            NaN                                        NaN   \n4                            NaN                                        NaN   \n...                          ...                                        ...   \n443825                [HCD, HCD]                  [1.2000000476840569, 2.0]   \n443826                [HCD, HCD]                  [1.2000000476840569, 2.0]   \n443827                       NaN                                        NaN   \n443828           [HCD, HCD, HCD]  [1.2000000476840569, 2.0, 2.200000047684]   \n443829           [HCD, HCD, HCD]  [1.2000000476840569, 2.0, 2.200000047684]   \n\n                          inchi_key compound_name  exact_mass  \\\n0       LXFOLMYKSYSZQS-LURJZOHASA-N  pinometostat  562.337987   \n1       LXFOLMYKSYSZQS-LURJZOHASA-N  pinometostat  562.337987   \n2       LXFOLMYKSYSZQS-LURJZOHASA-N  pinometostat  562.337987   \n3       LXFOLMYKSYSZQS-LURJZOHASA-N  pinometostat  562.337987   \n4       LXFOLMYKSYSZQS-LURJZOHASA-N  pinometostat  562.337987   \n...                             ...           ...         ...   \n443825  XGALLCVXEZPNRQ-UHFFFAOYSA-N     Gefitinib  446.152097   \n443826  XGALLCVXEZPNRQ-UHFFFAOYSA-N     Gefitinib  446.152097   \n443827  XGALLCVXEZPNRQ-UHFFFAOYSA-N     Gefitinib  446.152097   \n443828  XGALLCVXEZPNRQ-UHFFFAOYSA-N     Gefitinib  446.152097   \n443829  XGALLCVXEZPNRQ-UHFFFAOYSA-N     Gefitinib  446.152097   \n\n             lib_plate_well  \n0        pluskal_mce_1D1_J1  \n1        pluskal_mce_1D1_J1  \n2        pluskal_mce_1D1_J1  \n3        pluskal_mce_1D1_J1  \n4        pluskal_mce_1D1_J1  \n...                     ...  \n443825  pluskal_mce_1D3_J24  \n443826  pluskal_mce_1D3_J24  \n443827  pluskal_mce_1D3_J24  \n443828  pluskal_mce_1D3_J24  \n443829  pluskal_mce_1D3_J24  \n\n[443830 rows x 38 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula</th>\n      <th>inchi</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>fragmentation_method</th>\n      <th>isolation_window</th>\n      <th>msn_collision_energies</th>\n      <th>msn_precursor_mzs</th>\n      <th>msn_fragmentation_methods</th>\n      <th>msn_isolation_windows</th>\n      <th>inchi_key</th>\n      <th>compound_name</th>\n      <th>exact_mass</th>\n      <th>lib_plate_well</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>pinometostat</td>\n      <td>562.337987</td>\n      <td>pluskal_mce_1D1_J1</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>pinometostat</td>\n      <td>562.337987</td>\n      <td>pluskal_mce_1D1_J1</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>pinometostat</td>\n      <td>562.337987</td>\n      <td>pluskal_mce_1D1_J1</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>pinometostat</td>\n      <td>562.337987</td>\n      <td>pluskal_mce_1D1_J1</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>pinometostat</td>\n      <td>562.337987</td>\n      <td>pluskal_mce_1D1_J1</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>443825</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>[30.0, 40.0]</td>\n      <td>[447.159820556641, 128.106857299805]</td>\n      <td>[HCD, HCD]</td>\n      <td>[1.2000000476840569, 2.0]</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>Gefitinib</td>\n      <td>446.152097</td>\n      <td>pluskal_mce_1D3_J24</td>\n    </tr>\n    <tr>\n      <th>443826</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>[30.0, 20.0]</td>\n      <td>[447.159820556641, 128.106857299805]</td>\n      <td>[HCD, HCD]</td>\n      <td>[1.2000000476840569, 2.0]</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>Gefitinib</td>\n      <td>446.152097</td>\n      <td>pluskal_mce_1D3_J24</td>\n    </tr>\n    <tr>\n      <th>443827</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>Gefitinib</td>\n      <td>446.152097</td>\n      <td>pluskal_mce_1D3_J24</td>\n    </tr>\n    <tr>\n      <th>443828</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>[30.0, 40.0, 40.0]</td>\n      <td>[447.159820556641, 128.106857299805, 100.07565...</td>\n      <td>[HCD, HCD, HCD]</td>\n      <td>[1.2000000476840569, 2.0, 2.200000047684]</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>Gefitinib</td>\n      <td>446.152097</td>\n      <td>pluskal_mce_1D3_J24</td>\n    </tr>\n    <tr>\n      <th>443829</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>[30.0, 40.0, 20.0]</td>\n      <td>[447.159820556641, 128.106857299805, 100.07565...</td>\n      <td>[HCD, HCD, HCD]</td>\n      <td>[1.2000000476840569, 2.0, 2.200000047684]</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>Gefitinib</td>\n      <td>446.152097</td>\n      <td>pluskal_mce_1D3_J24</td>\n    </tr>\n  </tbody>\n</table>\n<p>443830 rows × 38 columns</p>\n</div>"
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "rows = []\n",
    "\n",
    "with pyteomics.mgf.MGF(infile) as f_in:\n",
    "    for spectrum_dict in tqdm(f_in):\n",
    "        rows.append(spectrum_dict[\"params\"])\n",
    "\n",
    "df = pd.DataFrame(rows)\n",
    "if \"inchi_key\" not in df.columns:\n",
    "    df[\"inchi_key\"] = df[\"inchiaux\"]\n",
    "if \"compound_name\" not in df.columns:\n",
    "    df[\"compound_name\"] = df[\"name\"]\n",
    "if \"exact_mass\" not in df.columns:\n",
    "    df[\"exact_mass\"] = df[\"exactmass\"]\n",
    "\n",
    "if \"usi\" in df.columns:\n",
    "    df[\"lib_plate_well\"] = [\"pluskal{}\".format(re.search(r'pluskal(.*?).mzML', usi).group(1))  for usi in df[\"usi\"]]\n",
    "\n",
    "df"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "outputs": [
    {
     "data": {
      "text/plain": "6986"
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"name\"].nunique()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "outputs": [
    {
     "data": {
      "text/plain": "                                 name                      description  \\\n0                        pinometostat  MCE bioactive compounds library   \n112                       894002-50-7  MCE bioactive compounds library   \n191                          AMG 9810  MCE bioactive compounds library   \n272                           AZD1208  MCE bioactive compounds library   \n331     4'-Demethylepipodophyllotoxin  MCE bioactive compounds library   \n...                               ...                              ...   \n443701        DL-Methionine sulfoxide  MCE bioactive compounds library   \n443718                        67-07-2  MCE bioactive compounds library   \n443738                      Gefitinib  MCE bioactive compounds library   \n443782                     Cyclic AMP  MCE bioactive compounds library   \n443810                       Turanose  MCE bioactive compounds library   \n\n         exactmass      formula_x  \\\n0       562.337987     C30H42N8O3   \n112     293.098668      C17H15N3S   \n191     337.167794      C21H23NO3   \n272     379.135448    C21H21N3O2S   \n331     400.115818       C21H20O8   \n...            ...            ...   \n443701  165.045964      C5H11NO3S   \n443718  211.035807     C4H10N3O5P   \n443738  446.152097  C22H24ClFN4O3   \n443782   329.05252    C10H12N5O6P   \n443810  342.116212      C12H22O11   \n\n                                                  inchi_x  \\\n0       InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n112     InChI=1S/C17H15N3S/c1-13-6-2-3-7-14(13)12-21-1...   \n191     InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)...   \n272     InChI=1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19...   \n331     InChI=1S/C21H20O8/c1-25-15-3-9(4-16(26-2)20(15...   \n...                                                   ...   \n443701  InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2...   \n443718  InChI=1S/C4H10N3O5P/c1-7(2-3(8)9)4(5)6-13(10,1...   \n443738  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443782  InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-...   \n443810  InChI=1S/C12H22O11/c13-1-4(16)7(18)11(5(17)2-1...   \n\n                           inchiaux  \\\n0       LXFOLMYKSYSZQS-LURJZOHASA-N   \n112     DUUQLWDHNYFUPP-UHFFFAOYSA-N   \n191     GZTFUVZVLYUPRG-IZZDOVSWSA-N   \n272     MCUJKPPARUPFJM-UWCCDQBKSA-N   \n331     YVCVYCSAAZQOJI-JHQYFNNDSA-N   \n...                             ...   \n443701  QEFRNWWLZKMPFJ-UHFFFAOYSA-N   \n443718  DRBBFCLWYRJSJZ-UHFFFAOYSA-N   \n443738  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443782  IVOMOUWHDPKRLL-KQYNXXCUSA-N   \n443810  RULSWEULPANCDV-PIXUTMIVSA-N   \n\n                                                   smiles mslevel         rt  \\\n0       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n112                        Cc1ccccc1CSc1nnc(-c2ccccn2)cc1       2  1.8745602   \n191         CC(C)(C)c1ccc(/C=C/C(=O)Nc2cc3c(cc2)OCCO3)cc1       2  1.8745602   \n272     N[C@@H]1CCCN(c2c(/C=C3\\SC(=O)NC3=O)cccc2-c2ccc...       2  1.2474549   \n331     COc1cc([C@@H]2c3cc4c(cc3[C@@H](O)[C@H]3COC(=O)...       2  0.7853385   \n...                                                   ...     ...        ...   \n443701                            C[S+]([O-])CCC(N)C(=O)O       2  1.2923726   \n443718                         CN(CC(=O)O)C(N)=NP(=O)(O)O       2  1.8714751   \n443738   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       2  1.8714751   \n443782  Nc1c2ncn([C@@H]3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]...       2  1.8682407   \n443810  O=C(CO)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](...       2  1.1997029   \n\n       precursor_type  ...                               drugcentral_synonyms  \\\n0            [M+2H]2+  ...                                                NaN   \n112            [M+H]+  ...                                                NaN   \n191            [M+H]+  ...                                                NaN   \n272            [M+H]+  ...                                                NaN   \n331        [M-H2O+H]+  ...                                                NaN   \n...               ...  ...                                                ...   \n443701         [M+H]+  ...                                                NaN   \n443718         [M+H]+  ...  fosfocreatine,N-Phosphorocreatine,N-Phosphoryl...   \n443738       [M+2H]2+  ...                    gefitinib,iressa,ZD 1839,ZD1839   \n443782         [M+H]+  ...                                                NaN   \n443810        [M+Na]+  ...                                                NaN   \n\n       drugcentral_pharma_type  \\\n0                          NaN   \n112                        NaN   \n191                        NaN   \n272                        NaN   \n331                        NaN   \n...                        ...   \n443701                     NaN   \n443718             has role,PA   \n443738     EPC,has role,MoA,PA   \n443782                     NaN   \n443810                     NaN   \n\n                                 drugcentral_pharma_class drugcentral_atc  \\\n0                                                     NaN             NaN   \n112                                                   NaN             NaN   \n191                                                   NaN             NaN   \n272                                                   NaN             NaN   \n331                                                   NaN             NaN   \n...                                                   ...             ...   \n443701                                                NaN             NaN   \n443718  Cardiotonic Agents,Cardiovascular Agents,Homo ...         C01EB06   \n443738  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443782                                                NaN             NaN   \n443810                                                NaN             NaN   \n\n       drugcentral_dosage drugbank_approved_number  \\\n0                     NaN                      NaN   \n112                   NaN                      NaN   \n191                   NaN                      NaN   \n272                   NaN                      NaN   \n331                   NaN                      NaN   \n...                   ...                      ...   \n443701                NaN                      NaN   \n443718                NaN                      NaN   \n443738              250mg                      4.0   \n443782                NaN                      NaN   \n443810                NaN                      NaN   \n\n       drugcentral_administration_number any_phase  none lib_plate_well_unique  \n0                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n112                                  NaN     False  56.0   pluskal_mce_1D1_J1.  \n191                                  NaN     False  52.0   pluskal_mce_1D1_J1.  \n272                                  NaN      True  51.0   pluskal_mce_1D1_J1.  \n331                                  NaN     False  55.0   pluskal_mce_1D1_J1.  \n...                                  ...       ...   ...                   ...  \n443701                               NaN      True  58.0  pluskal_mce_1D3_J24.  \n443718                               NaN      True  27.0  pluskal_mce_1D3_J24.  \n443738                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443782                               NaN      True  42.0  pluskal_mce_1D3_J24.  \n443810                               NaN     False  65.0  pluskal_mce_1D3_J24.  \n\n[7003 rows x 132 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>112</th>\n      <td>894002-50-7</td>\n      <td>MCE bioactive compounds library</td>\n      <td>293.098668</td>\n      <td>C17H15N3S</td>\n      <td>InChI=1S/C17H15N3S/c1-13-6-2-3-7-14(13)12-21-1...</td>\n      <td>DUUQLWDHNYFUPP-UHFFFAOYSA-N</td>\n      <td>Cc1ccccc1CSc1nnc(-c2ccccn2)cc1</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>56.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>191</th>\n      <td>AMG 9810</td>\n      <td>MCE bioactive compounds library</td>\n      <td>337.167794</td>\n      <td>C21H23NO3</td>\n      <td>InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)...</td>\n      <td>GZTFUVZVLYUPRG-IZZDOVSWSA-N</td>\n      <td>CC(C)(C)c1ccc(/C=C/C(=O)Nc2cc3c(cc2)OCCO3)cc1</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>52.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>272</th>\n      <td>AZD1208</td>\n      <td>MCE bioactive compounds library</td>\n      <td>379.135448</td>\n      <td>C21H21N3O2S</td>\n      <td>InChI=1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19...</td>\n      <td>MCUJKPPARUPFJM-UWCCDQBKSA-N</td>\n      <td>N[C@@H]1CCCN(c2c(/C=C3\\SC(=O)NC3=O)cccc2-c2ccc...</td>\n      <td>2</td>\n      <td>1.2474549</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>51.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>331</th>\n      <td>4'-Demethylepipodophyllotoxin</td>\n      <td>MCE bioactive compounds library</td>\n      <td>400.115818</td>\n      <td>C21H20O8</td>\n      <td>InChI=1S/C21H20O8/c1-25-15-3-9(4-16(26-2)20(15...</td>\n      <td>YVCVYCSAAZQOJI-JHQYFNNDSA-N</td>\n      <td>COc1cc([C@@H]2c3cc4c(cc3[C@@H](O)[C@H]3COC(=O)...</td>\n      <td>2</td>\n      <td>0.7853385</td>\n      <td>[M-H2O+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>55.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>443701</th>\n      <td>DL-Methionine sulfoxide</td>\n      <td>MCE bioactive compounds library</td>\n      <td>165.045964</td>\n      <td>C5H11NO3S</td>\n      <td>InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2...</td>\n      <td>QEFRNWWLZKMPFJ-UHFFFAOYSA-N</td>\n      <td>C[S+]([O-])CCC(N)C(=O)O</td>\n      <td>2</td>\n      <td>1.2923726</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>58.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443718</th>\n      <td>67-07-2</td>\n      <td>MCE bioactive compounds library</td>\n      <td>211.035807</td>\n      <td>C4H10N3O5P</td>\n      <td>InChI=1S/C4H10N3O5P/c1-7(2-3(8)9)4(5)6-13(10,1...</td>\n      <td>DRBBFCLWYRJSJZ-UHFFFAOYSA-N</td>\n      <td>CN(CC(=O)O)C(N)=NP(=O)(O)O</td>\n      <td>2</td>\n      <td>1.8714751</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>fosfocreatine,N-Phosphorocreatine,N-Phosphoryl...</td>\n      <td>has role,PA</td>\n      <td>Cardiotonic Agents,Cardiovascular Agents,Homo ...</td>\n      <td>C01EB06</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>27.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443738</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>2</td>\n      <td>1.8714751</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443782</th>\n      <td>Cyclic AMP</td>\n      <td>MCE bioactive compounds library</td>\n      <td>329.05252</td>\n      <td>C10H12N5O6P</td>\n      <td>InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-...</td>\n      <td>IVOMOUWHDPKRLL-KQYNXXCUSA-N</td>\n      <td>Nc1c2ncn([C@@H]3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]...</td>\n      <td>2</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443810</th>\n      <td>Turanose</td>\n      <td>MCE bioactive compounds library</td>\n      <td>342.116212</td>\n      <td>C12H22O11</td>\n      <td>InChI=1S/C12H22O11/c13-1-4(16)7(18)11(5(17)2-1...</td>\n      <td>RULSWEULPANCDV-PIXUTMIVSA-N</td>\n      <td>O=C(CO)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](...</td>\n      <td>2</td>\n      <td>1.1997029</td>\n      <td>[M+Na]+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>65.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n  </tbody>\n</table>\n<p>7003 rows × 132 columns</p>\n</div>"
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filtered_df = df.drop_duplicates([\"inchi_key_x\", \"lib_plate_well\"])\n",
    "filtered_df"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\BrungsC\\AppData\\Local\\Temp\\ipykernel_9564\\1632131621.py:1: DtypeWarning: Columns (35,36,38,52,84,85,86) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  libdf = pd.read_csv(r\"C:\\git\\msn_library\\data\\final_tables\\mce_library_all_final.tsv\", sep=\"\\t\")\n"
     ]
    },
    {
     "data": {
      "text/plain": "         Cat. No.                     Product Name  \\\n0        HY-17406                        Tolcapone   \n1        HY-B0023                     Azelnidipine   \n2        HY-B1664                    Iopanoic acid   \n3        HY-B1451        Imidapril (hydrochloride)   \n4        HY-15516                    Sotagliflozin   \n...           ...                              ...   \n10655   HY-101984          N6,N6-Dimethyladenosine   \n10656  HY-124540B  (Rac)-ABT-202 (dihydrochloride)   \n10657    HY-N2374                        Eupatorin   \n10658   HY-101879  Acridine Orange (hydrochloride)   \n10659  HY-101792A             RG7800 hydrochloride   \n\n                                                synonyms       CAS No.  \\\n0      ['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...   134308-13-7   \n1      ['Azelnidipine', '123524-52-7', 'CS 905', '3-(...   123524-52-7   \n2      ['Iopanoic acid', '96-83-3', 'Iodopanoic acid'...       96-83-3   \n3      ['Imidapril (hydrochloride)', '89396-94-1', 'T...    89396-94-1   \n4      ['Sotagliflozin', '1018899-04-1', 'LX-4211', '...  1018899-04-1   \n...                                                  ...           ...   \n10655  ['N6,N6-Dimethyladenosine', '2620-62-4', 'N,N-...     2620-62-4   \n10656  ['(Rac)-ABT-202 (dihydrochloride)', '1258641-3...  1258641-38-1   \n10657  ['Eupatorin', '855-96-9', \"3',5-Dihydroxy-4',6...      855-96-9   \n10658  ['Acridine Orange (hydrochloride)', '65-61-2',...       65-61-2   \n10659                           ['RG7800 hydrochloride']           NaN   \n\n                                                  Smiles  pubchem_cid  \\\n0           Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1    4659569.0   \n1      CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...      65948.0   \n2                         CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O       3735.0   \n3      CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O...    5485193.0   \n4      CCOc1ccc(Cc2c(Cl)ccc([C@@H]3O[C@H](SC)[C@@H](O...   24831714.0   \n...                                                  ...          ...   \n10655  CN(C)c1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C...     440004.0   \n10656                                 NC1CCN(c2cnccc2)C1   50988405.0   \n10657      COc1c(O)cc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1      97214.0   \n10658                 CN(C)c1cc2c(cc1)cc1ccc(N(C)C)cc1n2     517204.0   \n10659                                                NaN          NaN   \n\n                                         isomeric_smiles  \\\n0      CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...   \n1      CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)...   \n2                      CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O   \n3      CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[...   \n4      CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C...   \n...                                                  ...   \n10655  CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H...   \n10656                        C1CN(CC1N)C2=CN=CC=C2.Cl.Cl   \n10657  COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)O...   \n10658       CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C.Cl   \n10659                                                NaN   \n\n                                        canonical_smiles  \\\n0           Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1   \n1      CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...   \n2                         CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O   \n3      CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C...   \n4        CCOc1ccc(Cc2c(Cl)ccc(C3OC(SC)C(O)C(O)C3O)c2)cc1   \n...                                                  ...   \n10655                  CN(C)c1ncnc2c1ncn2C1OC(CO)C(O)C1O   \n10656                                 NC1CCN(c2cnccc2)C1   \n10657      COc1c(O)cc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1   \n10658                 CN(C)c1cc2c(cc1)cc1ccc(N(C)C)cc1n2   \n10659                                                NaN   \n\n      mixed_location_plate1       lib_plate_well  ...  \\\n0                   1D2_P21  pluskal_mce_1D2_P21  ...   \n1                   1D1_D10  pluskal_mce_1D1_D10  ...   \n2                   1D1_M21  pluskal_mce_1D1_M21  ...   \n3                   1D2_O18  pluskal_mce_1D2_O18  ...   \n4                    1D1_A8   pluskal_mce_1D1_A8  ...   \n...                     ...                  ...  ...   \n10655                1D2_P2   pluskal_mce_1D2_P2  ...   \n10656                1D1_D2   pluskal_mce_1D1_D2  ...   \n10657                1D3_A7   pluskal_mce_1D3_A7  ...   \n10658                1D2_P2   pluskal_mce_1D2_P2  ...   \n10659               1D3_L17  pluskal_mce_1D3_L17  ...   \n\n                                    drugcentral_synonyms  \\\n0                            RO 40-7592,tasmar,tolcapone   \n1                           azelnidipine,calblock,CS-905   \n2      iodopanic acid,iodopanoic acid,iopanoic acid,i...   \n3      imidapril,imidapril HCl,imidapril hydrochlorid...   \n4       LP-802034,LX-4211,LX4211,sotagliflozin,zynquista   \n...                                                  ...   \n10655                                                NaN   \n10656                                                NaN   \n10657                                                NaN   \n10658                                                NaN   \n10659                                                NaN   \n\n      drugcentral_pharma_type  \\\n0         EPC,has role,MoA,PA   \n1                         NaN   \n2                          PA   \n3                 has role,PA   \n4                          PA   \n...                       ...   \n10655                     NaN   \n10656                     NaN   \n10657                     NaN   \n10658                     NaN   \n10659                     NaN   \n\n                                drugcentral_pharma_class drugcentral_atc  \\\n0      Anti-Dyskinesia Agents,antiparkinson agent,Ant...         N04BX01   \n1                                                    NaN             NaN   \n2            Contrast Media,Diagnostic Uses of Chemicals         V08AC06   \n3      ACE inhibitor,Angiotensin-Converting Enzyme In...         C09AA16   \n4      Hypoglycemic Agents,Sodium-Glucose Transporter...         A10BK06   \n...                                                  ...             ...   \n10655                                                NaN             NaN   \n10656                                                NaN             NaN   \n10657                                                NaN             NaN   \n10658                                                NaN             NaN   \n10659                                                NaN             NaN   \n\n      drugcentral_dosage drugbank_approved_number  \\\n0                  100mg                      4.0   \n1                    NaN                      NaN   \n2                    NaN                      4.0   \n3                    NaN                      NaN   \n4                    NaN                      4.0   \n...                  ...                      ...   \n10655                NaN                      NaN   \n10656                NaN                      NaN   \n10657                NaN                      NaN   \n10658                NaN                      NaN   \n10659                NaN                      NaN   \n\n       drugcentral_administration_number any_phase none lib_plate_well_unique  \n0                                    4.0      True    3  pluskal_mce_1D2_P21.  \n1                                    NaN      True   23  pluskal_mce_1D1_D10.  \n2                                    4.0      True   22  pluskal_mce_1D1_M21.  \n3                                    4.0      True   22  pluskal_mce_1D2_O18.  \n4                                    4.0      True   22   pluskal_mce_1D1_A8.  \n...                                  ...       ...  ...                   ...  \n10655                                NaN     False   55   pluskal_mce_1D2_P2.  \n10656                                NaN     False   55   pluskal_mce_1D1_D2.  \n10657                                NaN     False   55   pluskal_mce_1D3_A7.  \n10658                                NaN     False   55   pluskal_mce_1D2_P2.  \n10659                                NaN     False   84  pluskal_mce_1D3_L17.  \n\n[10660 rows x 97 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>lib_plate_well</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>HY-17406</td>\n      <td>Tolcapone</td>\n      <td>['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...</td>\n      <td>134308-13-7</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>4659569.0</td>\n      <td>CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>1D2_P21</td>\n      <td>pluskal_mce_1D2_P21</td>\n      <td>...</td>\n      <td>RO 40-7592,tasmar,tolcapone</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Anti-Dyskinesia Agents,antiparkinson agent,Ant...</td>\n      <td>N04BX01</td>\n      <td>100mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>3</td>\n      <td>pluskal_mce_1D2_P21.</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>HY-B0023</td>\n      <td>Azelnidipine</td>\n      <td>['Azelnidipine', '123524-52-7', 'CS 905', '3-(...</td>\n      <td>123524-52-7</td>\n      <td>CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...</td>\n      <td>65948.0</td>\n      <td>CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)...</td>\n      <td>CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...</td>\n      <td>1D1_D10</td>\n      <td>pluskal_mce_1D1_D10</td>\n      <td>...</td>\n      <td>azelnidipine,calblock,CS-905</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>23</td>\n      <td>pluskal_mce_1D1_D10.</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>HY-B1664</td>\n      <td>Iopanoic acid</td>\n      <td>['Iopanoic acid', '96-83-3', 'Iodopanoic acid'...</td>\n      <td>96-83-3</td>\n      <td>CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O</td>\n      <td>3735.0</td>\n      <td>CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O</td>\n      <td>CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O</td>\n      <td>1D1_M21</td>\n      <td>pluskal_mce_1D1_M21</td>\n      <td>...</td>\n      <td>iodopanic acid,iodopanoic acid,iopanoic acid,i...</td>\n      <td>PA</td>\n      <td>Contrast Media,Diagnostic Uses of Chemicals</td>\n      <td>V08AC06</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D1_M21.</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>HY-B1451</td>\n      <td>Imidapril (hydrochloride)</td>\n      <td>['Imidapril (hydrochloride)', '89396-94-1', 'T...</td>\n      <td>89396-94-1</td>\n      <td>CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O...</td>\n      <td>5485193.0</td>\n      <td>CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[...</td>\n      <td>CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C...</td>\n      <td>1D2_O18</td>\n      <td>pluskal_mce_1D2_O18</td>\n      <td>...</td>\n      <td>imidapril,imidapril HCl,imidapril hydrochlorid...</td>\n      <td>has role,PA</td>\n      <td>ACE inhibitor,Angiotensin-Converting Enzyme In...</td>\n      <td>C09AA16</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D2_O18.</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>HY-15516</td>\n      <td>Sotagliflozin</td>\n      <td>['Sotagliflozin', '1018899-04-1', 'LX-4211', '...</td>\n      <td>1018899-04-1</td>\n      <td>CCOc1ccc(Cc2c(Cl)ccc([C@@H]3O[C@H](SC)[C@@H](O...</td>\n      <td>24831714.0</td>\n      <td>CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C...</td>\n      <td>CCOc1ccc(Cc2c(Cl)ccc(C3OC(SC)C(O)C(O)C3O)c2)cc1</td>\n      <td>1D1_A8</td>\n      <td>pluskal_mce_1D1_A8</td>\n      <td>...</td>\n      <td>LP-802034,LX-4211,LX4211,sotagliflozin,zynquista</td>\n      <td>PA</td>\n      <td>Hypoglycemic Agents,Sodium-Glucose Transporter...</td>\n      <td>A10BK06</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D1_A8.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>10655</th>\n      <td>HY-101984</td>\n      <td>N6,N6-Dimethyladenosine</td>\n      <td>['N6,N6-Dimethyladenosine', '2620-62-4', 'N,N-...</td>\n      <td>2620-62-4</td>\n      <td>CN(C)c1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C...</td>\n      <td>440004.0</td>\n      <td>CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H...</td>\n      <td>CN(C)c1ncnc2c1ncn2C1OC(CO)C(O)C1O</td>\n      <td>1D2_P2</td>\n      <td>pluskal_mce_1D2_P2</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>55</td>\n      <td>pluskal_mce_1D2_P2.</td>\n    </tr>\n    <tr>\n      <th>10656</th>\n      <td>HY-124540B</td>\n      <td>(Rac)-ABT-202 (dihydrochloride)</td>\n      <td>['(Rac)-ABT-202 (dihydrochloride)', '1258641-3...</td>\n      <td>1258641-38-1</td>\n      <td>NC1CCN(c2cnccc2)C1</td>\n      <td>50988405.0</td>\n      <td>C1CN(CC1N)C2=CN=CC=C2.Cl.Cl</td>\n      <td>NC1CCN(c2cnccc2)C1</td>\n      <td>1D1_D2</td>\n      <td>pluskal_mce_1D1_D2</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>55</td>\n      <td>pluskal_mce_1D1_D2.</td>\n    </tr>\n    <tr>\n      <th>10657</th>\n      <td>HY-N2374</td>\n      <td>Eupatorin</td>\n      <td>['Eupatorin', '855-96-9', \"3',5-Dihydroxy-4',6...</td>\n      <td>855-96-9</td>\n      <td>COc1c(O)cc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1</td>\n      <td>97214.0</td>\n      <td>COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)O...</td>\n      <td>COc1c(O)cc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1</td>\n      <td>1D3_A7</td>\n      <td>pluskal_mce_1D3_A7</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>55</td>\n      <td>pluskal_mce_1D3_A7.</td>\n    </tr>\n    <tr>\n      <th>10658</th>\n      <td>HY-101879</td>\n      <td>Acridine Orange (hydrochloride)</td>\n      <td>['Acridine Orange (hydrochloride)', '65-61-2',...</td>\n      <td>65-61-2</td>\n      <td>CN(C)c1cc2c(cc1)cc1ccc(N(C)C)cc1n2</td>\n      <td>517204.0</td>\n      <td>CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C.Cl</td>\n      <td>CN(C)c1cc2c(cc1)cc1ccc(N(C)C)cc1n2</td>\n      <td>1D2_P2</td>\n      <td>pluskal_mce_1D2_P2</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>55</td>\n      <td>pluskal_mce_1D2_P2.</td>\n    </tr>\n    <tr>\n      <th>10659</th>\n      <td>HY-101792A</td>\n      <td>RG7800 hydrochloride</td>\n      <td>['RG7800 hydrochloride']</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>1D3_L17</td>\n      <td>pluskal_mce_1D3_L17</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>84</td>\n      <td>pluskal_mce_1D3_L17.</td>\n    </tr>\n  </tbody>\n</table>\n<p>10660 rows × 97 columns</p>\n</div>"
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "libdf = pd.read_csv(r\"C:\\git\\msn_library\\data\\final_tables\\mce_library_all_final.tsv\", sep=\"\\t\")\n",
    "libdf"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "outputs": [
    {
     "data": {
      "text/plain": "                                       Cat. No.  Product Name  synonyms  \\\nlib_plate_well     compound_name                                          \npluskal_mce_1D1_A1 4egi-1                     1             1         1   \n                   ALK inhibitor 1            1             1         1   \n                   Brevianamide F             1             1         1   \n                   CCT007093                  1             1         1   \n                   CH5132799                  1             1         1   \n...                                         ...           ...       ...   \npluskal_mce_1D3_L9 CCG-63808                  1             1         1   \n                   Coenzyme Q9                1             1         1   \n                   Dihydrocholesterol         1             1         1   \n                   LY2794193                  1             1         1   \n                   Leonurine                  1             1         1   \n\n                                       CAS No.  Smiles  pubchem_cid  \\\nlib_plate_well     compound_name                                      \npluskal_mce_1D1_A1 4egi-1                    1       1            1   \n                   ALK inhibitor 1           1       1            1   \n                   Brevianamide F            1       1            1   \n                   CCT007093                 1       1            1   \n                   CH5132799                 1       1            1   \n...                                        ...     ...          ...   \npluskal_mce_1D3_L9 CCG-63808                 1       1            1   \n                   Coenzyme Q9               1       1            1   \n                   Dihydrocholesterol        1       1            1   \n                   LY2794193                 1       1            1   \n                   Leonurine                 1       1            1   \n\n                                       isomeric_smiles  canonical_smiles  \\\nlib_plate_well     compound_name                                           \npluskal_mce_1D1_A1 4egi-1                            1                 1   \n                   ALK inhibitor 1                   1                 1   \n                   Brevianamide F                    1                 1   \n                   CCT007093                         1                 1   \n                   CH5132799                         1                 1   \n...                                                ...               ...   \npluskal_mce_1D3_L9 CCG-63808                         1                 1   \n                   Coenzyme Q9                       1                 1   \n                   Dihydrocholesterol                1                 1   \n                   LY2794193                         1                 1   \n                   Leonurine                         1                 1   \n\n                                       mixed_location_plate1  URL  ...  \\\nlib_plate_well     compound_name                                   ...   \npluskal_mce_1D1_A1 4egi-1                                  1    1  ...   \n                   ALK inhibitor 1                         1    1  ...   \n                   Brevianamide F                          1    1  ...   \n                   CCT007093                               1    1  ...   \n                   CH5132799                               1    1  ...   \n...                                                      ...  ...  ...   \npluskal_mce_1D3_L9 CCG-63808                               1    0  ...   \n                   Coenzyme Q9                             1    0  ...   \n                   Dihydrocholesterol                      1    0  ...   \n                   LY2794193                               1    0  ...   \n                   Leonurine                               1    0  ...   \n\n                                       drugcentral_synonyms  \\\nlib_plate_well     compound_name                              \npluskal_mce_1D1_A1 4egi-1                                 0   \n                   ALK inhibitor 1                        0   \n                   Brevianamide F                         0   \n                   CCT007093                              0   \n                   CH5132799                              0   \n...                                                     ...   \npluskal_mce_1D3_L9 CCG-63808                              0   \n                   Coenzyme Q9                            0   \n                   Dihydrocholesterol                     0   \n                   LY2794193                              0   \n                   Leonurine                              0   \n\n                                       drugcentral_pharma_type  \\\nlib_plate_well     compound_name                                 \npluskal_mce_1D1_A1 4egi-1                                    0   \n                   ALK inhibitor 1                           0   \n                   Brevianamide F                            0   \n                   CCT007093                                 0   \n                   CH5132799                                 0   \n...                                                        ...   \npluskal_mce_1D3_L9 CCG-63808                                 0   \n                   Coenzyme Q9                               0   \n                   Dihydrocholesterol                        0   \n                   LY2794193                                 0   \n                   Leonurine                                 0   \n\n                                       drugcentral_pharma_class  \\\nlib_plate_well     compound_name                                  \npluskal_mce_1D1_A1 4egi-1                                     0   \n                   ALK inhibitor 1                            0   \n                   Brevianamide F                             0   \n                   CCT007093                                  0   \n                   CH5132799                                  0   \n...                                                         ...   \npluskal_mce_1D3_L9 CCG-63808                                  0   \n                   Coenzyme Q9                                0   \n                   Dihydrocholesterol                         0   \n                   LY2794193                                  0   \n                   Leonurine                                  0   \n\n                                       drugcentral_atc  drugcentral_dosage  \\\nlib_plate_well     compound_name                                             \npluskal_mce_1D1_A1 4egi-1                            0                   0   \n                   ALK inhibitor 1                   0                   0   \n                   Brevianamide F                    0                   0   \n                   CCT007093                         0                   0   \n                   CH5132799                         0                   0   \n...                                                ...                 ...   \npluskal_mce_1D3_L9 CCG-63808                         0                   0   \n                   Coenzyme Q9                       0                   0   \n                   Dihydrocholesterol                0                   0   \n                   LY2794193                         0                   0   \n                   Leonurine                         0                   0   \n\n                                       drugbank_approved_number  \\\nlib_plate_well     compound_name                                  \npluskal_mce_1D1_A1 4egi-1                                     0   \n                   ALK inhibitor 1                            0   \n                   Brevianamide F                             0   \n                   CCT007093                                  0   \n                   CH5132799                                  0   \n...                                                         ...   \npluskal_mce_1D3_L9 CCG-63808                                  0   \n                   Coenzyme Q9                                0   \n                   Dihydrocholesterol                         0   \n                   LY2794193                                  0   \n                   Leonurine                                  0   \n\n                                       drugcentral_administration_number  \\\nlib_plate_well     compound_name                                           \npluskal_mce_1D1_A1 4egi-1                                              0   \n                   ALK inhibitor 1                                     0   \n                   Brevianamide F                                      0   \n                   CCT007093                                           0   \n                   CH5132799                                           0   \n...                                                                  ...   \npluskal_mce_1D3_L9 CCG-63808                                           0   \n                   Coenzyme Q9                                         0   \n                   Dihydrocholesterol                                  0   \n                   LY2794193                                           0   \n                   Leonurine                                           0   \n\n                                       any_phase  none  lib_plate_well_unique  \nlib_plate_well     compound_name                                               \npluskal_mce_1D1_A1 4egi-1                      1     1                      1  \n                   ALK inhibitor 1             1     1                      1  \n                   Brevianamide F              1     1                      1  \n                   CCT007093                   1     1                      1  \n                   CH5132799                   1     1                      1  \n...                                          ...   ...                    ...  \npluskal_mce_1D3_L9 CCG-63808                   1     1                      1  \n                   Coenzyme Q9                 1     1                      1  \n                   Dihydrocholesterol          1     1                      1  \n                   LY2794193                   1     1                      1  \n                   Leonurine                   1     1                      1  \n\n[10626 rows x 95 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>URL</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n    <tr>\n      <th>lib_plate_well</th>\n      <th>compound_name</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th rowspan=\"5\" valign=\"top\">pluskal_mce_1D1_A1</th>\n      <th>4egi-1</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>ALK inhibitor 1</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>Brevianamide F</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>CCT007093</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>CH5132799</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th rowspan=\"5\" valign=\"top\">pluskal_mce_1D3_L9</th>\n      <th>CCG-63808</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>0</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>Coenzyme Q9</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>0</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>Dihydrocholesterol</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>0</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>LY2794193</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>0</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>Leonurine</th>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n      <td>0</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1</td>\n      <td>1</td>\n      <td>1</td>\n    </tr>\n  </tbody>\n</table>\n<p>10626 rows × 95 columns</p>\n</div>"
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "libdf.groupby([\"lib_plate_well\", \"compound_name\"]).count()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "outputs": [
    {
     "data": {
      "text/plain": "       Cat. No.              Product Name  \\\n0      HY-17406                 Tolcapone   \n1866   HY-B0261                 Meloxicam   \n1867  HY-13756A  Tacrolimus (monohydrate)   \n1868   HY-A0057                Gabapentin   \n1869  HY-A0013A        Bosentan (hydrate)   \n...         ...                       ...   \n6333  HY-129939      PROTAC BRD4 ligand-1   \n6188   HY-15943                   6-TAMRA   \n6185  HY-101916           Heparan Sulfate   \n6331  HY-114336                 Enocyanin   \n6221  HY-101888   cresyl Violet (acetate)   \n\n                                               synonyms       CAS No.  \\\n0     ['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...   134308-13-7   \n1866  ['Meloxicam', '71125-38-7', 'Mobic', 'Metacam'...    71125-38-7   \n1867  ['Tacrolimus (monohydrate)', '109581-93-3', 'F...   109581-93-3   \n1868  ['Gabapentin', '60142-96-3', 'Neurontin', '1-(...    60142-96-3   \n1869  ['Bosentan (hydrate)', '157212-55-0', 'Bosenta...   157212-55-0   \n...                                                 ...           ...   \n6333  ['PROTAC BRD4 ligand-1', '2313230-51-0', 'EX-A...  2313230-51-0   \n6188  ['6-TAMRA', '91809-67-5', '6-Carboxytetramethy...    91809-67-5   \n6185                   ['Heparan Sulfate', '9050-30-0']     9050-30-0   \n6331  ['Enocyanin', '11029-12-2', 'Flavylium', '2-ph...    11029-12-2   \n6221  ['cresyl Violet (acetate)', '10510-54-0', '9-a...    10510-54-0   \n\n                                                 Smiles  pubchem_cid  \\\n0          Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1    4659569.0   \n1866        Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1   54677470.0   \n1867  C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[...    5282315.0   \n1868                                NCC1(CC(=O)O)CCCCC1       3446.0   \n1869  COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...     185462.0   \n...                                                 ...          ...   \n6333  Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...  142572767.0   \n6188  CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...    2762604.0   \n6185  CO[C@@H]1OC(COS(=O)(=O)O)[C@H](O[C@@H]2OC(C(=O...  137699201.0   \n6331                       c1ccc(-c2[o+]c3ccccc3cc2)cc1     145858.0   \n6221                 N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12      82686.0   \n\n                                        isomeric_smiles  \\\n0     CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...   \n1866   CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O   \n1867  C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(...   \n1868                              C1CCC(CC1)(CC(=O)O)CN   \n1869  CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)...   \n...                                                 ...   \n6333  CN1C=C2C3=C(C=C(C(=C3)CS(=O)(=O)C)C(=O)O)N(CC4...   \n6188  CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)...   \n6185  CO[C@@H]1[C@@H]([C@@H]([C@@H](OC1C(=O)[O-])O[C...   \n6331                C1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C=C2   \n6221  CC(=O)[O-].C1=CC=C2C(=C1)C(=[NH2+])C=C3C2=NC4=...   \n\n                                       canonical_smiles mixed_location_plate1  \\\n0          Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1               1D2_P21   \n1866        Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1               1D2_I14   \n1867  C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCC...                1D3_A8   \n1868                                NCC1(CC(=O)O)CCCCC1                1D3_K3   \n1869  COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...               1D1_E14   \n...                                                 ...                   ...   \n6333  Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...               1D3_K22   \n6188  CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...               1D3_K22   \n6185  COC1OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(COS...               1D3_L19   \n6331                       c1ccc(-c2[o+]c3ccccc3cc2)cc1               1D3_L15   \n6221                 N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12               1D3_K20   \n\n           lib_plate_well  ...  \\\n0     pluskal_mce_1D2_P21  ...   \n1866  pluskal_mce_1D2_I14  ...   \n1867   pluskal_mce_1D3_A8  ...   \n1868   pluskal_mce_1D3_K3  ...   \n1869  pluskal_mce_1D1_E14  ...   \n...                   ...  ...   \n6333  pluskal_mce_1D3_K22  ...   \n6188  pluskal_mce_1D3_K22  ...   \n6185  pluskal_mce_1D3_L19  ...   \n6331  pluskal_mce_1D3_L15  ...   \n6221  pluskal_mce_1D3_K20  ...   \n\n                                   drugcentral_synonyms  \\\n0                           RO 40-7592,tasmar,tolcapone   \n1866  meloxicam,meloxicam sodium,meloxicam sodium hy...   \n1867  anhydrous tacrolimus,FK-506,FR900506,fujimycin...   \n1868   gabamox,gabapen,gabapentin,gabapentine,neurontin   \n1869  actelion,bosentan,bosentan anhydrous,bosentan ...   \n...                                                 ...   \n6333                                                NaN   \n6188                                                NaN   \n6185                                                NaN   \n6331                                                NaN   \n6221                                                NaN   \n\n     drugcentral_pharma_type  \\\n0        EPC,has role,MoA,PA   \n1866  CS,EPC,has role,MoA,PA   \n1867     EPC,has role,MoA,PA   \n1868      EPC,has role,PA,PE   \n1869     EPC,has role,MoA,PA   \n...                      ...   \n6333                     NaN   \n6188                     NaN   \n6185                     NaN   \n6331                     NaN   \n6221                     NaN   \n\n                               drugcentral_pharma_class  \\\n0     Anti-Dyskinesia Agents,antiparkinson agent,Ant...   \n1866  Analgesics,Analgesics, Non-Narcotic,Anti-Infla...   \n1867  Calcineurin Inhibitor Immunosuppressant,Calcin...   \n1868  Analgesics,Anti-Anxiety Agents,Anti-epileptic ...   \n1869  Antihypertensive Agents,antihypertensive drugs...   \n...                                                 ...   \n6333                                                NaN   \n6188                                                NaN   \n6185                                                NaN   \n6331                                                NaN   \n6221                                                NaN   \n\n              drugcentral_atc  \\\n0                     N04BX01   \n1866  M01AC06,M01AC56,N01BB59   \n1867          D11AH01,L04AD02   \n1868                  N03AX12   \n1869                  C02KX01   \n...                       ...   \n6333                      NaN   \n6188                      NaN   \n6185                      NaN   \n6331                      NaN   \n6221                      NaN   \n\n                                     drugcentral_dosage  \\\n0                                                 100mg   \n1866        1.8mg,10mg,12mg,15mg,30mg,5mg,6mg,7.5mg,9mg   \n1867  0.03g,0.1g,0.2mg,0.3mg,0.5mg,0.75mg,1mg,30mg,4...   \n1868                100mg,250mg,300mg,400mg,600mg,800mg   \n1869                                  125mg,32mg,62.5mg   \n...                                                 ...   \n6333                                                NaN   \n6188                                                NaN   \n6185                                                NaN   \n6331                                                NaN   \n6221                                                NaN   \n\n     drugbank_approved_number  drugcentral_administration_number any_phase  \\\n0                         4.0                                4.0      True   \n1866                      4.0                                4.0      True   \n1867                      4.0                                4.0      True   \n1868                      4.0                                4.0      True   \n1869                      4.0                                4.0      True   \n...                       ...                                ...       ...   \n6333                      NaN                                NaN     False   \n6188                      NaN                                NaN     False   \n6185                      NaN                                NaN     False   \n6331                      NaN                                NaN     False   \n6221                      NaN                                NaN     False   \n\n     none lib_plate_well_unique  \n0       3  pluskal_mce_1D2_P21.  \n1866    4  pluskal_mce_1D2_I14.  \n1867    4   pluskal_mce_1D3_A8.  \n1868    4   pluskal_mce_1D3_K3.  \n1869    4  pluskal_mce_1D1_E14.  \n...   ...                   ...  \n6333   72  pluskal_mce_1D3_K22.  \n6188   72  pluskal_mce_1D3_K22.  \n6185   72  pluskal_mce_1D3_L19.  \n6331   72  pluskal_mce_1D3_L15.  \n6221   72  pluskal_mce_1D3_K20.  \n\n[10507 rows x 97 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>lib_plate_well</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>HY-17406</td>\n      <td>Tolcapone</td>\n      <td>['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...</td>\n      <td>134308-13-7</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>4659569.0</td>\n      <td>CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>1D2_P21</td>\n      <td>pluskal_mce_1D2_P21</td>\n      <td>...</td>\n      <td>RO 40-7592,tasmar,tolcapone</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Anti-Dyskinesia Agents,antiparkinson agent,Ant...</td>\n      <td>N04BX01</td>\n      <td>100mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>3</td>\n      <td>pluskal_mce_1D2_P21.</td>\n    </tr>\n    <tr>\n      <th>1866</th>\n      <td>HY-B0261</td>\n      <td>Meloxicam</td>\n      <td>['Meloxicam', '71125-38-7', 'Mobic', 'Metacam'...</td>\n      <td>71125-38-7</td>\n      <td>Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1</td>\n      <td>54677470.0</td>\n      <td>CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O</td>\n      <td>Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1</td>\n      <td>1D2_I14</td>\n      <td>pluskal_mce_1D2_I14</td>\n      <td>...</td>\n      <td>meloxicam,meloxicam sodium,meloxicam sodium hy...</td>\n      <td>CS,EPC,has role,MoA,PA</td>\n      <td>Analgesics,Analgesics, Non-Narcotic,Anti-Infla...</td>\n      <td>M01AC06,M01AC56,N01BB59</td>\n      <td>1.8mg,10mg,12mg,15mg,30mg,5mg,6mg,7.5mg,9mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D2_I14.</td>\n    </tr>\n    <tr>\n      <th>1867</th>\n      <td>HY-13756A</td>\n      <td>Tacrolimus (monohydrate)</td>\n      <td>['Tacrolimus (monohydrate)', '109581-93-3', 'F...</td>\n      <td>109581-93-3</td>\n      <td>C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[...</td>\n      <td>5282315.0</td>\n      <td>C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(...</td>\n      <td>C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCC...</td>\n      <td>1D3_A8</td>\n      <td>pluskal_mce_1D3_A8</td>\n      <td>...</td>\n      <td>anhydrous tacrolimus,FK-506,FR900506,fujimycin...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Calcineurin Inhibitor Immunosuppressant,Calcin...</td>\n      <td>D11AH01,L04AD02</td>\n      <td>0.03g,0.1g,0.2mg,0.3mg,0.5mg,0.75mg,1mg,30mg,4...</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D3_A8.</td>\n    </tr>\n    <tr>\n      <th>1868</th>\n      <td>HY-A0057</td>\n      <td>Gabapentin</td>\n      <td>['Gabapentin', '60142-96-3', 'Neurontin', '1-(...</td>\n      <td>60142-96-3</td>\n      <td>NCC1(CC(=O)O)CCCCC1</td>\n      <td>3446.0</td>\n      <td>C1CCC(CC1)(CC(=O)O)CN</td>\n      <td>NCC1(CC(=O)O)CCCCC1</td>\n      <td>1D3_K3</td>\n      <td>pluskal_mce_1D3_K3</td>\n      <td>...</td>\n      <td>gabamox,gabapen,gabapentin,gabapentine,neurontin</td>\n      <td>EPC,has role,PA,PE</td>\n      <td>Analgesics,Anti-Anxiety Agents,Anti-epileptic ...</td>\n      <td>N03AX12</td>\n      <td>100mg,250mg,300mg,400mg,600mg,800mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D3_K3.</td>\n    </tr>\n    <tr>\n      <th>1869</th>\n      <td>HY-A0013A</td>\n      <td>Bosentan (hydrate)</td>\n      <td>['Bosentan (hydrate)', '157212-55-0', 'Bosenta...</td>\n      <td>157212-55-0</td>\n      <td>COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...</td>\n      <td>185462.0</td>\n      <td>CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)...</td>\n      <td>COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...</td>\n      <td>1D1_E14</td>\n      <td>pluskal_mce_1D1_E14</td>\n      <td>...</td>\n      <td>actelion,bosentan,bosentan anhydrous,bosentan ...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Antihypertensive Agents,antihypertensive drugs...</td>\n      <td>C02KX01</td>\n      <td>125mg,32mg,62.5mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D1_E14.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>6333</th>\n      <td>HY-129939</td>\n      <td>PROTAC BRD4 ligand-1</td>\n      <td>['PROTAC BRD4 ligand-1', '2313230-51-0', 'EX-A...</td>\n      <td>2313230-51-0</td>\n      <td>Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...</td>\n      <td>142572767.0</td>\n      <td>CN1C=C2C3=C(C=C(C(=C3)CS(=O)(=O)C)C(=O)O)N(CC4...</td>\n      <td>Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...</td>\n      <td>1D3_K22</td>\n      <td>pluskal_mce_1D3_K22</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_K22.</td>\n    </tr>\n    <tr>\n      <th>6188</th>\n      <td>HY-15943</td>\n      <td>6-TAMRA</td>\n      <td>['6-TAMRA', '91809-67-5', '6-Carboxytetramethy...</td>\n      <td>91809-67-5</td>\n      <td>CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...</td>\n      <td>2762604.0</td>\n      <td>CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)...</td>\n      <td>CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...</td>\n      <td>1D3_K22</td>\n      <td>pluskal_mce_1D3_K22</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_K22.</td>\n    </tr>\n    <tr>\n      <th>6185</th>\n      <td>HY-101916</td>\n      <td>Heparan Sulfate</td>\n      <td>['Heparan Sulfate', '9050-30-0']</td>\n      <td>9050-30-0</td>\n      <td>CO[C@@H]1OC(COS(=O)(=O)O)[C@H](O[C@@H]2OC(C(=O...</td>\n      <td>137699201.0</td>\n      <td>CO[C@@H]1[C@@H]([C@@H]([C@@H](OC1C(=O)[O-])O[C...</td>\n      <td>COC1OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(COS...</td>\n      <td>1D3_L19</td>\n      <td>pluskal_mce_1D3_L19</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_L19.</td>\n    </tr>\n    <tr>\n      <th>6331</th>\n      <td>HY-114336</td>\n      <td>Enocyanin</td>\n      <td>['Enocyanin', '11029-12-2', 'Flavylium', '2-ph...</td>\n      <td>11029-12-2</td>\n      <td>c1ccc(-c2[o+]c3ccccc3cc2)cc1</td>\n      <td>145858.0</td>\n      <td>C1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C=C2</td>\n      <td>c1ccc(-c2[o+]c3ccccc3cc2)cc1</td>\n      <td>1D3_L15</td>\n      <td>pluskal_mce_1D3_L15</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_L15.</td>\n    </tr>\n    <tr>\n      <th>6221</th>\n      <td>HY-101888</td>\n      <td>cresyl Violet (acetate)</td>\n      <td>['cresyl Violet (acetate)', '10510-54-0', '9-a...</td>\n      <td>10510-54-0</td>\n      <td>N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12</td>\n      <td>82686.0</td>\n      <td>CC(=O)[O-].C1=CC=C2C(=C1)C(=[NH2+])C=C3C2=NC4=...</td>\n      <td>N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12</td>\n      <td>1D3_K20</td>\n      <td>pluskal_mce_1D3_K20</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_K20.</td>\n    </tr>\n  </tbody>\n</table>\n<p>10507 rows × 97 columns</p>\n</div>"
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "libdf = libdf.sort_values(by=\"none\")\n",
    "libdf = libdf[libdf[\"exact_mass\"].notna()]\n",
    "libdf = libdf.drop_duplicates([\"lib_plate_well\", \"compound_name\", \"exact_mass\"])\n",
    "libdf"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "outputs": [
    {
     "data": {
      "text/plain": "Empty DataFrame\nColumns: [Cat. No., Product Name, synonyms, CAS No., Smiles, pubchem_cid, isomeric_smiles, canonical_smiles, mixed_location_plate1, lib_plate_well, URL, Target, Information, Pathway, Research Area, Source, exact_mass, inchi, inchi_key, split_inchi_key, formula, pubchem_cid_parent, compound_name, iupac, pubchem_logp, unii, schembl_id, chembl_id, zinc_id, drugbank_id, molecular_species, prodrug, clinical_phase, first_approval, withdrawn, withdrawn_class, withdrawn_reason, withdrawn_year, withdrawn_country, oral, parenteral, topical, natural_product, usan_stem_definition, chembl_alogp, chembl_clogp, indication, broad_pert_iname, broad_moa, broad_target, broad_disease_area, broad_indication, clinical_phase_description, drugbank_name, drugbank_chembl_id, drugbank_pubchem_cid, drugbank_cas, drugbank_unii, drugbank_type, drugbank_description, drugbank_approved, drugbank_indication, drugbank_pharmacodynamics, drugbank_mechanism_of_action, drugbank_toxicity, drugbank_metabolism, drugbank_absorption, drugbank_half_life, drugbank_route_of_elimination, drugbank_clearance, drugbank_atc_code, drugbank_mode_of_action, drugbank_food_interaction, drugbank_targets, drugcentral_id, drugcentral_cas_reg_no, drugcentral_name, drugcentral_inchikey, drugcentral_inchi, drugcentral_smiles, drugcentral_stem, drugcentral_mrdef, drugcentral_status, drugcentral_database_id, drugcentral_date_of_approval, drugcentral_administration, drugcentral_orphan, drugcentral_synonyms, drugcentral_pharma_type, drugcentral_pharma_class, drugcentral_atc, drugcentral_dosage, drugbank_approved_number, drugcentral_administration_number, any_phase, none, lib_plate_well_unique]\nIndex: []\n\n[0 rows x 97 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>lib_plate_well</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n  </tbody>\n</table>\n<p>0 rows × 97 columns</p>\n</div>"
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "libdf[libdf[\"compound_name\"]==\"V5 Epitope Tag Peptide (Trifluoroacetate)\"]"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "outputs": [
    {
     "data": {
      "text/plain": "       Cat. No.              Product Name  \\\n0      HY-17406                 Tolcapone   \n1866   HY-B0261                 Meloxicam   \n1867  HY-13756A  Tacrolimus (monohydrate)   \n1868   HY-A0057                Gabapentin   \n1869  HY-A0013A        Bosentan (hydrate)   \n...         ...                       ...   \n6333  HY-129939      PROTAC BRD4 ligand-1   \n6188   HY-15943                   6-TAMRA   \n6185  HY-101916           Heparan Sulfate   \n6331  HY-114336                 Enocyanin   \n6221  HY-101888   cresyl Violet (acetate)   \n\n                                               synonyms       CAS No.  \\\n0     ['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...   134308-13-7   \n1866  ['Meloxicam', '71125-38-7', 'Mobic', 'Metacam'...    71125-38-7   \n1867  ['Tacrolimus (monohydrate)', '109581-93-3', 'F...   109581-93-3   \n1868  ['Gabapentin', '60142-96-3', 'Neurontin', '1-(...    60142-96-3   \n1869  ['Bosentan (hydrate)', '157212-55-0', 'Bosenta...   157212-55-0   \n...                                                 ...           ...   \n6333  ['PROTAC BRD4 ligand-1', '2313230-51-0', 'EX-A...  2313230-51-0   \n6188  ['6-TAMRA', '91809-67-5', '6-Carboxytetramethy...    91809-67-5   \n6185                   ['Heparan Sulfate', '9050-30-0']     9050-30-0   \n6331  ['Enocyanin', '11029-12-2', 'Flavylium', '2-ph...    11029-12-2   \n6221  ['cresyl Violet (acetate)', '10510-54-0', '9-a...    10510-54-0   \n\n                                                 Smiles  pubchem_cid  \\\n0          Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1    4659569.0   \n1866        Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1   54677470.0   \n1867  C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[...    5282315.0   \n1868                                NCC1(CC(=O)O)CCCCC1       3446.0   \n1869  COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...     185462.0   \n...                                                 ...          ...   \n6333  Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...  142572767.0   \n6188  CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...    2762604.0   \n6185  CO[C@@H]1OC(COS(=O)(=O)O)[C@H](O[C@@H]2OC(C(=O...  137699201.0   \n6331                       c1ccc(-c2[o+]c3ccccc3cc2)cc1     145858.0   \n6221                 N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12      82686.0   \n\n                                        isomeric_smiles  \\\n0     CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...   \n1866   CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O   \n1867  C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(...   \n1868                              C1CCC(CC1)(CC(=O)O)CN   \n1869  CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)...   \n...                                                 ...   \n6333  CN1C=C2C3=C(C=C(C(=C3)CS(=O)(=O)C)C(=O)O)N(CC4...   \n6188  CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)...   \n6185  CO[C@@H]1[C@@H]([C@@H]([C@@H](OC1C(=O)[O-])O[C...   \n6331                C1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C=C2   \n6221  CC(=O)[O-].C1=CC=C2C(=C1)C(=[NH2+])C=C3C2=NC4=...   \n\n                                       canonical_smiles mixed_location_plate1  \\\n0          Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1               1D2_P21   \n1866        Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1               1D2_I14   \n1867  C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCC...                1D3_A8   \n1868                                NCC1(CC(=O)O)CCCCC1                1D3_K3   \n1869  COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...               1D1_E14   \n...                                                 ...                   ...   \n6333  Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...               1D3_K22   \n6188  CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...               1D3_K22   \n6185  COC1OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(COS...               1D3_L19   \n6331                       c1ccc(-c2[o+]c3ccccc3cc2)cc1               1D3_L15   \n6221                 N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12               1D3_K20   \n\n           lib_plate_well  ...  \\\n0     pluskal_mce_1D2_P21  ...   \n1866  pluskal_mce_1D2_I14  ...   \n1867   pluskal_mce_1D3_A8  ...   \n1868   pluskal_mce_1D3_K3  ...   \n1869  pluskal_mce_1D1_E14  ...   \n...                   ...  ...   \n6333  pluskal_mce_1D3_K22  ...   \n6188  pluskal_mce_1D3_K22  ...   \n6185  pluskal_mce_1D3_L19  ...   \n6331  pluskal_mce_1D3_L15  ...   \n6221  pluskal_mce_1D3_K20  ...   \n\n                                   drugcentral_synonyms  \\\n0                           RO 40-7592,tasmar,tolcapone   \n1866  meloxicam,meloxicam sodium,meloxicam sodium hy...   \n1867  anhydrous tacrolimus,FK-506,FR900506,fujimycin...   \n1868   gabamox,gabapen,gabapentin,gabapentine,neurontin   \n1869  actelion,bosentan,bosentan anhydrous,bosentan ...   \n...                                                 ...   \n6333                                                NaN   \n6188                                                NaN   \n6185                                                NaN   \n6331                                                NaN   \n6221                                                NaN   \n\n     drugcentral_pharma_type  \\\n0        EPC,has role,MoA,PA   \n1866  CS,EPC,has role,MoA,PA   \n1867     EPC,has role,MoA,PA   \n1868      EPC,has role,PA,PE   \n1869     EPC,has role,MoA,PA   \n...                      ...   \n6333                     NaN   \n6188                     NaN   \n6185                     NaN   \n6331                     NaN   \n6221                     NaN   \n\n                               drugcentral_pharma_class  \\\n0     Anti-Dyskinesia Agents,antiparkinson agent,Ant...   \n1866  Analgesics,Analgesics, Non-Narcotic,Anti-Infla...   \n1867  Calcineurin Inhibitor Immunosuppressant,Calcin...   \n1868  Analgesics,Anti-Anxiety Agents,Anti-epileptic ...   \n1869  Antihypertensive Agents,antihypertensive drugs...   \n...                                                 ...   \n6333                                                NaN   \n6188                                                NaN   \n6185                                                NaN   \n6331                                                NaN   \n6221                                                NaN   \n\n              drugcentral_atc  \\\n0                     N04BX01   \n1866  M01AC06,M01AC56,N01BB59   \n1867          D11AH01,L04AD02   \n1868                  N03AX12   \n1869                  C02KX01   \n...                       ...   \n6333                      NaN   \n6188                      NaN   \n6185                      NaN   \n6331                      NaN   \n6221                      NaN   \n\n                                     drugcentral_dosage  \\\n0                                                 100mg   \n1866        1.8mg,10mg,12mg,15mg,30mg,5mg,6mg,7.5mg,9mg   \n1867  0.03g,0.1g,0.2mg,0.3mg,0.5mg,0.75mg,1mg,30mg,4...   \n1868                100mg,250mg,300mg,400mg,600mg,800mg   \n1869                                  125mg,32mg,62.5mg   \n...                                                 ...   \n6333                                                NaN   \n6188                                                NaN   \n6185                                                NaN   \n6331                                                NaN   \n6221                                                NaN   \n\n     drugbank_approved_number  drugcentral_administration_number any_phase  \\\n0                         4.0                                4.0      True   \n1866                      4.0                                4.0      True   \n1867                      4.0                                4.0      True   \n1868                      4.0                                4.0      True   \n1869                      4.0                                4.0      True   \n...                       ...                                ...       ...   \n6333                      NaN                                NaN     False   \n6188                      NaN                                NaN     False   \n6185                      NaN                                NaN     False   \n6331                      NaN                                NaN     False   \n6221                      NaN                                NaN     False   \n\n     none lib_plate_well_unique  \n0       3  pluskal_mce_1D2_P21.  \n1866    4  pluskal_mce_1D2_I14.  \n1867    4   pluskal_mce_1D3_A8.  \n1868    4   pluskal_mce_1D3_K3.  \n1869    4  pluskal_mce_1D1_E14.  \n...   ...                   ...  \n6333   72  pluskal_mce_1D3_K22.  \n6188   72  pluskal_mce_1D3_K22.  \n6185   72  pluskal_mce_1D3_L19.  \n6331   72  pluskal_mce_1D3_L15.  \n6221   72  pluskal_mce_1D3_K20.  \n\n[10504 rows x 97 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>lib_plate_well</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>HY-17406</td>\n      <td>Tolcapone</td>\n      <td>['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...</td>\n      <td>134308-13-7</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>4659569.0</td>\n      <td>CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>1D2_P21</td>\n      <td>pluskal_mce_1D2_P21</td>\n      <td>...</td>\n      <td>RO 40-7592,tasmar,tolcapone</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Anti-Dyskinesia Agents,antiparkinson agent,Ant...</td>\n      <td>N04BX01</td>\n      <td>100mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>3</td>\n      <td>pluskal_mce_1D2_P21.</td>\n    </tr>\n    <tr>\n      <th>1866</th>\n      <td>HY-B0261</td>\n      <td>Meloxicam</td>\n      <td>['Meloxicam', '71125-38-7', 'Mobic', 'Metacam'...</td>\n      <td>71125-38-7</td>\n      <td>Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1</td>\n      <td>54677470.0</td>\n      <td>CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O</td>\n      <td>Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1</td>\n      <td>1D2_I14</td>\n      <td>pluskal_mce_1D2_I14</td>\n      <td>...</td>\n      <td>meloxicam,meloxicam sodium,meloxicam sodium hy...</td>\n      <td>CS,EPC,has role,MoA,PA</td>\n      <td>Analgesics,Analgesics, Non-Narcotic,Anti-Infla...</td>\n      <td>M01AC06,M01AC56,N01BB59</td>\n      <td>1.8mg,10mg,12mg,15mg,30mg,5mg,6mg,7.5mg,9mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D2_I14.</td>\n    </tr>\n    <tr>\n      <th>1867</th>\n      <td>HY-13756A</td>\n      <td>Tacrolimus (monohydrate)</td>\n      <td>['Tacrolimus (monohydrate)', '109581-93-3', 'F...</td>\n      <td>109581-93-3</td>\n      <td>C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[...</td>\n      <td>5282315.0</td>\n      <td>C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(...</td>\n      <td>C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCC...</td>\n      <td>1D3_A8</td>\n      <td>pluskal_mce_1D3_A8</td>\n      <td>...</td>\n      <td>anhydrous tacrolimus,FK-506,FR900506,fujimycin...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Calcineurin Inhibitor Immunosuppressant,Calcin...</td>\n      <td>D11AH01,L04AD02</td>\n      <td>0.03g,0.1g,0.2mg,0.3mg,0.5mg,0.75mg,1mg,30mg,4...</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D3_A8.</td>\n    </tr>\n    <tr>\n      <th>1868</th>\n      <td>HY-A0057</td>\n      <td>Gabapentin</td>\n      <td>['Gabapentin', '60142-96-3', 'Neurontin', '1-(...</td>\n      <td>60142-96-3</td>\n      <td>NCC1(CC(=O)O)CCCCC1</td>\n      <td>3446.0</td>\n      <td>C1CCC(CC1)(CC(=O)O)CN</td>\n      <td>NCC1(CC(=O)O)CCCCC1</td>\n      <td>1D3_K3</td>\n      <td>pluskal_mce_1D3_K3</td>\n      <td>...</td>\n      <td>gabamox,gabapen,gabapentin,gabapentine,neurontin</td>\n      <td>EPC,has role,PA,PE</td>\n      <td>Analgesics,Anti-Anxiety Agents,Anti-epileptic ...</td>\n      <td>N03AX12</td>\n      <td>100mg,250mg,300mg,400mg,600mg,800mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D3_K3.</td>\n    </tr>\n    <tr>\n      <th>1869</th>\n      <td>HY-A0013A</td>\n      <td>Bosentan (hydrate)</td>\n      <td>['Bosentan (hydrate)', '157212-55-0', 'Bosenta...</td>\n      <td>157212-55-0</td>\n      <td>COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...</td>\n      <td>185462.0</td>\n      <td>CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)...</td>\n      <td>COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)...</td>\n      <td>1D1_E14</td>\n      <td>pluskal_mce_1D1_E14</td>\n      <td>...</td>\n      <td>actelion,bosentan,bosentan anhydrous,bosentan ...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Antihypertensive Agents,antihypertensive drugs...</td>\n      <td>C02KX01</td>\n      <td>125mg,32mg,62.5mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>4</td>\n      <td>pluskal_mce_1D1_E14.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>6333</th>\n      <td>HY-129939</td>\n      <td>PROTAC BRD4 ligand-1</td>\n      <td>['PROTAC BRD4 ligand-1', '2313230-51-0', 'EX-A...</td>\n      <td>2313230-51-0</td>\n      <td>Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...</td>\n      <td>142572767.0</td>\n      <td>CN1C=C2C3=C(C=C(C(=C3)CS(=O)(=O)C)C(=O)O)N(CC4...</td>\n      <td>Cn1cc2-c3c(cc(C(=O)O)c(CS(C)(=O)=O)c3)N(c3c(F)...</td>\n      <td>1D3_K22</td>\n      <td>pluskal_mce_1D3_K22</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_K22.</td>\n    </tr>\n    <tr>\n      <th>6188</th>\n      <td>HY-15943</td>\n      <td>6-TAMRA</td>\n      <td>['6-TAMRA', '91809-67-5', '6-Carboxytetramethy...</td>\n      <td>91809-67-5</td>\n      <td>CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...</td>\n      <td>2762604.0</td>\n      <td>CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)...</td>\n      <td>CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)ccc(C(=O)[O-])c1...</td>\n      <td>1D3_K22</td>\n      <td>pluskal_mce_1D3_K22</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_K22.</td>\n    </tr>\n    <tr>\n      <th>6185</th>\n      <td>HY-101916</td>\n      <td>Heparan Sulfate</td>\n      <td>['Heparan Sulfate', '9050-30-0']</td>\n      <td>9050-30-0</td>\n      <td>CO[C@@H]1OC(COS(=O)(=O)O)[C@H](O[C@@H]2OC(C(=O...</td>\n      <td>137699201.0</td>\n      <td>CO[C@@H]1[C@@H]([C@@H]([C@@H](OC1C(=O)[O-])O[C...</td>\n      <td>COC1OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(COS...</td>\n      <td>1D3_L19</td>\n      <td>pluskal_mce_1D3_L19</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_L19.</td>\n    </tr>\n    <tr>\n      <th>6331</th>\n      <td>HY-114336</td>\n      <td>Enocyanin</td>\n      <td>['Enocyanin', '11029-12-2', 'Flavylium', '2-ph...</td>\n      <td>11029-12-2</td>\n      <td>c1ccc(-c2[o+]c3ccccc3cc2)cc1</td>\n      <td>145858.0</td>\n      <td>C1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C=C2</td>\n      <td>c1ccc(-c2[o+]c3ccccc3cc2)cc1</td>\n      <td>1D3_L15</td>\n      <td>pluskal_mce_1D3_L15</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_L15.</td>\n    </tr>\n    <tr>\n      <th>6221</th>\n      <td>HY-101888</td>\n      <td>cresyl Violet (acetate)</td>\n      <td>['cresyl Violet (acetate)', '10510-54-0', '9-a...</td>\n      <td>10510-54-0</td>\n      <td>N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12</td>\n      <td>82686.0</td>\n      <td>CC(=O)[O-].C1=CC=C2C(=C1)C(=[NH2+])C=C3C2=NC4=...</td>\n      <td>N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12</td>\n      <td>1D3_K20</td>\n      <td>pluskal_mce_1D3_K20</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>72</td>\n      <td>pluskal_mce_1D3_K20.</td>\n    </tr>\n  </tbody>\n</table>\n<p>10504 rows × 97 columns</p>\n</div>"
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "libdf.drop_duplicates([\"lib_plate_well\", \"compound_name\"])"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "libdf[]"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "libdf.loc"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "outputs": [
    {
     "data": {
      "text/plain": "                name                      description   exactmass  \\\n0       pinometostat  MCE bioactive compounds library  562.337987   \n1       pinometostat  MCE bioactive compounds library  562.337987   \n2       pinometostat  MCE bioactive compounds library  562.337987   \n3       pinometostat  MCE bioactive compounds library  562.337987   \n4       pinometostat  MCE bioactive compounds library  562.337987   \n...              ...                              ...         ...   \n443825     Gefitinib  MCE bioactive compounds library  446.152097   \n443826     Gefitinib  MCE bioactive compounds library  446.152097   \n443827     Gefitinib  MCE bioactive compounds library  446.152097   \n443828     Gefitinib  MCE bioactive compounds library  446.152097   \n443829     Gefitinib  MCE bioactive compounds library  446.152097   \n\n            formula_x                                            inchi_x  \\\n0          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n1          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n2          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n3          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n4          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n...               ...                                                ...   \n443825  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443826  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443827  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443828  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443829  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n\n                           inchiaux  \\\n0       LXFOLMYKSYSZQS-LURJZOHASA-N   \n1       LXFOLMYKSYSZQS-LURJZOHASA-N   \n2       LXFOLMYKSYSZQS-LURJZOHASA-N   \n3       LXFOLMYKSYSZQS-LURJZOHASA-N   \n4       LXFOLMYKSYSZQS-LURJZOHASA-N   \n...                             ...   \n443825  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443826  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443827  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443828  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443829  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n\n                                                   smiles mslevel         rt  \\\n0       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n1       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n2       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n3       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n4       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n...                                                   ...     ...        ...   \n443825   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443826   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443827   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443828   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443829   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n\n       precursor_type  ...             drugcentral_synonyms  \\\n0            [M+2H]2+  ...                              NaN   \n1            [M+2H]2+  ...                              NaN   \n2            [M+2H]2+  ...                              NaN   \n3            [M+2H]2+  ...                              NaN   \n4            [M+2H]2+  ...                              NaN   \n...               ...  ...                              ...   \n443825         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443826         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443827         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443828         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443829         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n\n       drugcentral_pharma_type  \\\n0                          NaN   \n1                          NaN   \n2                          NaN   \n3                          NaN   \n4                          NaN   \n...                        ...   \n443825     EPC,has role,MoA,PA   \n443826     EPC,has role,MoA,PA   \n443827     EPC,has role,MoA,PA   \n443828     EPC,has role,MoA,PA   \n443829     EPC,has role,MoA,PA   \n\n                                 drugcentral_pharma_class drugcentral_atc  \\\n0                                                     NaN             NaN   \n1                                                     NaN             NaN   \n2                                                     NaN             NaN   \n3                                                     NaN             NaN   \n4                                                     NaN             NaN   \n...                                                   ...             ...   \n443825  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443826  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443827  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443828  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443829  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n\n       drugcentral_dosage drugbank_approved_number  \\\n0                     NaN                      NaN   \n1                     NaN                      NaN   \n2                     NaN                      NaN   \n3                     NaN                      NaN   \n4                     NaN                      NaN   \n...                   ...                      ...   \n443825              250mg                      4.0   \n443826              250mg                      4.0   \n443827              250mg                      4.0   \n443828              250mg                      4.0   \n443829              250mg                      4.0   \n\n       drugcentral_administration_number any_phase  none lib_plate_well_unique  \n0                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n1                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n2                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n3                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n4                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n...                                  ...       ...   ...                   ...  \n443825                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443826                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443827                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443828                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443829                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n\n[443830 rows x 132 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>443825</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443826</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443827</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443828</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443829</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n  </tbody>\n</table>\n<p>443830 rows × 132 columns</p>\n</div>"
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"exact_mass\"] = df[\"exactmass\"].astype(\"float\")\n",
    "columns = [\"lib_plate_well\", \"compound_name\", \"exact_mass\"]\n",
    "df = df.merge(libdf, on=columns, how=\"left\")\n",
    "df"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "outputs": [
    {
     "data": {
      "text/plain": "                name                      description   exactmass  \\\n0       pinometostat  MCE bioactive compounds library  562.337987   \n1       pinometostat  MCE bioactive compounds library  562.337987   \n2       pinometostat  MCE bioactive compounds library  562.337987   \n3       pinometostat  MCE bioactive compounds library  562.337987   \n4       pinometostat  MCE bioactive compounds library  562.337987   \n...              ...                              ...         ...   \n443825     Gefitinib  MCE bioactive compounds library  446.152097   \n443826     Gefitinib  MCE bioactive compounds library  446.152097   \n443827     Gefitinib  MCE bioactive compounds library  446.152097   \n443828     Gefitinib  MCE bioactive compounds library  446.152097   \n443829     Gefitinib  MCE bioactive compounds library  446.152097   \n\n            formula_x                                            inchi_x  \\\n0          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n1          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n2          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n3          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n4          C30H42N8O3  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...   \n...               ...                                                ...   \n443825  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443826  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443827  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443828  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443829  C22H24ClFN4O3  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n\n                           inchiaux  \\\n0       LXFOLMYKSYSZQS-LURJZOHASA-N   \n1       LXFOLMYKSYSZQS-LURJZOHASA-N   \n2       LXFOLMYKSYSZQS-LURJZOHASA-N   \n3       LXFOLMYKSYSZQS-LURJZOHASA-N   \n4       LXFOLMYKSYSZQS-LURJZOHASA-N   \n...                             ...   \n443825  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443826  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443827  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443828  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443829  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n\n                                                   smiles mslevel         rt  \\\n0       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n1       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n2       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n3       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n4       CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...       2  1.8745602   \n...                                                   ...     ...        ...   \n443825   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443826   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443827   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443828   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443829   COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n\n       precursor_type  ...             drugcentral_synonyms  \\\n0            [M+2H]2+  ...                              NaN   \n1            [M+2H]2+  ...                              NaN   \n2            [M+2H]2+  ...                              NaN   \n3            [M+2H]2+  ...                              NaN   \n4            [M+2H]2+  ...                              NaN   \n...               ...  ...                              ...   \n443825         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443826         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443827         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443828         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443829         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n\n       drugcentral_pharma_type  \\\n0                          NaN   \n1                          NaN   \n2                          NaN   \n3                          NaN   \n4                          NaN   \n...                        ...   \n443825     EPC,has role,MoA,PA   \n443826     EPC,has role,MoA,PA   \n443827     EPC,has role,MoA,PA   \n443828     EPC,has role,MoA,PA   \n443829     EPC,has role,MoA,PA   \n\n                                 drugcentral_pharma_class drugcentral_atc  \\\n0                                                     NaN             NaN   \n1                                                     NaN             NaN   \n2                                                     NaN             NaN   \n3                                                     NaN             NaN   \n4                                                     NaN             NaN   \n...                                                   ...             ...   \n443825  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443826  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443827  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443828  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443829  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n\n       drugcentral_dosage drugbank_approved_number  \\\n0                     NaN                      NaN   \n1                     NaN                      NaN   \n2                     NaN                      NaN   \n3                     NaN                      NaN   \n4                     NaN                      NaN   \n...                   ...                      ...   \n443825              250mg                      4.0   \n443826              250mg                      4.0   \n443827              250mg                      4.0   \n443828              250mg                      4.0   \n443829              250mg                      4.0   \n\n       drugcentral_administration_number any_phase  none lib_plate_well_unique  \n0                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n1                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n2                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n3                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n4                                    NaN      True  42.0   pluskal_mce_1D1_J1.  \n...                                  ...       ...   ...                   ...  \n443825                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443826                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443827                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443828                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443829                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n\n[175495 rows x 132 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>pinometostat</td>\n      <td>MCE bioactive compounds library</td>\n      <td>562.337987</td>\n      <td>C30H42N8O3</td>\n      <td>InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(...</td>\n      <td>LXFOLMYKSYSZQS-LURJZOHASA-N</td>\n      <td>CC(C)N(C[C@H]1O[C@@H](n2cnc3c2ncnc3N)[C@H](O)[...</td>\n      <td>2</td>\n      <td>1.8745602</td>\n      <td>[M+2H]2+</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>42.0</td>\n      <td>pluskal_mce_1D1_J1.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>443825</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443826</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443827</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443828</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443829</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n  </tbody>\n</table>\n<p>175495 rows × 132 columns</p>\n</div>"
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phase_df = df[df[\"clinical_phase\"]>0]\n",
    "phase_df"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "outputs": [
    {
     "data": {
      "text/plain": "                             name  description  exactmass  formula_x  inchi_x  \\\ninchi_key_x                                                                     \nAAAQFGUYHFJNHI-SFHVURJKSA-N   198          198        198        198      198   \nAACUJFVOHGRMTR-DPXNYUHVSA-N    90           90         90         90       90   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N   119          119        119        119      119   \nAALSSIXXBDPENJ-FYWRMAATSA-N     9            9          9          9        9   \nABDDQTDRAHXHOC-QMMMGPOBSA-N    86           86         86         86       86   \n...                           ...          ...        ...        ...      ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N    66           66         66         66       66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N    59           59         59         59       59   \nZZORFUFYDOWNEF-UHFFFAOYSA-N    87           87         87         87       87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N    94           94         94         94       94   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N    40           40         40         40       40   \n\n                             inchiaux  smiles  mslevel   rt  precursor_type  \\\ninchi_key_x                                                                   \nAAAQFGUYHFJNHI-SFHVURJKSA-N       198     198      198  198             198   \nAACUJFVOHGRMTR-DPXNYUHVSA-N        90      90       90   90              90   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N       119     119      119  119             119   \nAALSSIXXBDPENJ-FYWRMAATSA-N         9       9        9    9               9   \nABDDQTDRAHXHOC-QMMMGPOBSA-N        86      86       86   86              86   \n...                               ...     ...      ...  ...             ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N        66      66       66   66              66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N        59      59       59   59              59   \nZZORFUFYDOWNEF-UHFFFAOYSA-N        87      87       87   87              87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N        94      94       94   94              94   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N        40      40       40   40              40   \n\n                             ...  drugcentral_synonyms  \\\ninchi_key_x                  ...                         \nAAAQFGUYHFJNHI-SFHVURJKSA-N  ...                     0   \nAACUJFVOHGRMTR-DPXNYUHVSA-N  ...                     0   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N  ...                   119   \nAALSSIXXBDPENJ-FYWRMAATSA-N  ...                     0   \nABDDQTDRAHXHOC-QMMMGPOBSA-N  ...                     0   \n...                          ...                   ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N  ...                    66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N  ...                     0   \nZZORFUFYDOWNEF-UHFFFAOYSA-N  ...                    87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N  ...                     0   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N  ...                     0   \n\n                             drugcentral_pharma_type  \\\ninchi_key_x                                            \nAAAQFGUYHFJNHI-SFHVURJKSA-N                        0   \nAACUJFVOHGRMTR-DPXNYUHVSA-N                        0   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                      119   \nAALSSIXXBDPENJ-FYWRMAATSA-N                        0   \nABDDQTDRAHXHOC-QMMMGPOBSA-N                        0   \n...                                              ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                       66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N                        0   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                       87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N                        0   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N                        0   \n\n                             drugcentral_pharma_class  drugcentral_atc  \\\ninchi_key_x                                                              \nAAAQFGUYHFJNHI-SFHVURJKSA-N                         0                0   \nAACUJFVOHGRMTR-DPXNYUHVSA-N                         0                0   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                       119              119   \nAALSSIXXBDPENJ-FYWRMAATSA-N                         0                0   \nABDDQTDRAHXHOC-QMMMGPOBSA-N                         0                0   \n...                                               ...              ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                        66               66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N                         0                0   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                        87               87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N                         0                0   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N                         0                0   \n\n                             drugcentral_dosage  drugbank_approved_number  \\\ninchi_key_x                                                                 \nAAAQFGUYHFJNHI-SFHVURJKSA-N                   0                         0   \nAACUJFVOHGRMTR-DPXNYUHVSA-N                   0                         0   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                 119                       119   \nAALSSIXXBDPENJ-FYWRMAATSA-N                   0                         0   \nABDDQTDRAHXHOC-QMMMGPOBSA-N                   0                         0   \n...                                         ...                       ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                   0                        66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N                   0                         0   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                   0                        87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N                   0                         0   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N                   0                         0   \n\n                             drugcentral_administration_number  any_phase  \\\ninchi_key_x                                                                 \nAAAQFGUYHFJNHI-SFHVURJKSA-N                                  0        198   \nAACUJFVOHGRMTR-DPXNYUHVSA-N                                  0         90   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                                119        119   \nAALSSIXXBDPENJ-FYWRMAATSA-N                                  0          9   \nABDDQTDRAHXHOC-QMMMGPOBSA-N                                  0         86   \n...                                                        ...        ...   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                                 66         66   \nZZJLMZYUGLJBSO-LAEOZQHASA-N                                  0         59   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                                  0         87   \nZZWJKLGCDHYVMB-BWGXUDETSA-N                                  0         94   \nZZWWXIBKLBMSCS-FQEVSTJZSA-N                                  0         40   \n\n                             none  lib_plate_well_unique  \ninchi_key_x                                               \nAAAQFGUYHFJNHI-SFHVURJKSA-N   198                    198  \nAACUJFVOHGRMTR-DPXNYUHVSA-N    90                     90  \nAAKJLRGGTJKAMG-UHFFFAOYSA-N   119                    119  \nAALSSIXXBDPENJ-FYWRMAATSA-N     9                      9  \nABDDQTDRAHXHOC-QMMMGPOBSA-N    86                     86  \n...                           ...                    ...  \nZZHLYYDVIOPZBE-UHFFFAOYSA-N    66                     66  \nZZJLMZYUGLJBSO-LAEOZQHASA-N    59                     59  \nZZORFUFYDOWNEF-UHFFFAOYSA-N    87                     87  \nZZWJKLGCDHYVMB-BWGXUDETSA-N    94                     94  \nZZWWXIBKLBMSCS-FQEVSTJZSA-N    40                     40  \n\n[2596 rows x 131 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n    <tr>\n      <th>inchi_key_x</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>AAAQFGUYHFJNHI-SFHVURJKSA-N</th>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>198</td>\n      <td>198</td>\n      <td>198</td>\n    </tr>\n    <tr>\n      <th>AACUJFVOHGRMTR-DPXNYUHVSA-N</th>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>90</td>\n      <td>90</td>\n      <td>90</td>\n    </tr>\n    <tr>\n      <th>AAKJLRGGTJKAMG-UHFFFAOYSA-N</th>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>...</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n    </tr>\n    <tr>\n      <th>AALSSIXXBDPENJ-FYWRMAATSA-N</th>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>9</td>\n      <td>9</td>\n      <td>9</td>\n    </tr>\n    <tr>\n      <th>ABDDQTDRAHXHOC-QMMMGPOBSA-N</th>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>86</td>\n      <td>86</td>\n      <td>86</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>ZZHLYYDVIOPZBE-UHFFFAOYSA-N</th>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>...</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>0</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n    </tr>\n    <tr>\n      <th>ZZJLMZYUGLJBSO-LAEOZQHASA-N</th>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n    </tr>\n    <tr>\n      <th>ZZORFUFYDOWNEF-UHFFFAOYSA-N</th>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>...</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>0</td>\n      <td>87</td>\n      <td>0</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n    </tr>\n    <tr>\n      <th>ZZWJKLGCDHYVMB-BWGXUDETSA-N</th>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>94</td>\n      <td>94</td>\n      <td>94</td>\n    </tr>\n    <tr>\n      <th>ZZWWXIBKLBMSCS-FQEVSTJZSA-N</th>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>40</td>\n      <td>40</td>\n      <td>40</td>\n    </tr>\n  </tbody>\n</table>\n<p>2596 rows × 131 columns</p>\n</div>"
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "phase_df.groupby(\"inchi_key_x\").count()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "outputs": [
    {
     "data": {
      "text/plain": "             name                      description   exactmass      formula_x  \\\n741      Icotinib  MCE bioactive compounds library  391.153206     C22H21N3O4   \n742      Icotinib  MCE bioactive compounds library  391.153206     C22H21N3O4   \n743      Icotinib  MCE bioactive compounds library  391.153206     C22H21N3O4   \n744      Icotinib  MCE bioactive compounds library  391.153206     C22H21N3O4   \n745      Icotinib  MCE bioactive compounds library  391.153206     C22H21N3O4   \n...           ...                              ...         ...            ...   \n443825  Gefitinib  MCE bioactive compounds library  446.152097  C22H24ClFN4O3   \n443826  Gefitinib  MCE bioactive compounds library  446.152097  C22H24ClFN4O3   \n443827  Gefitinib  MCE bioactive compounds library  446.152097  C22H24ClFN4O3   \n443828  Gefitinib  MCE bioactive compounds library  446.152097  C22H24ClFN4O3   \n443829  Gefitinib  MCE bioactive compounds library  446.152097  C22H24ClFN4O3   \n\n                                                  inchi_x  \\\n741     InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...   \n742     InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...   \n743     InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...   \n744     InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...   \n745     InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...   \n...                                                   ...   \n443825  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443826  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443827  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443828  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n443829  InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...   \n\n                           inchiaux  \\\n741     QQLKULDARVNMAL-UHFFFAOYSA-N   \n742     QQLKULDARVNMAL-UHFFFAOYSA-N   \n743     QQLKULDARVNMAL-UHFFFAOYSA-N   \n744     QQLKULDARVNMAL-UHFFFAOYSA-N   \n745     QQLKULDARVNMAL-UHFFFAOYSA-N   \n...                             ...   \n443825  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443826  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443827  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443828  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n443829  XGALLCVXEZPNRQ-UHFFFAOYSA-N   \n\n                                                  smiles mslevel         rt  \\\n741           C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1       2  1.1265261   \n742           C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1       2  1.1265261   \n743           C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1       2  1.1265261   \n744           C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1       2  1.1265261   \n745           C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1       2  1.1265261   \n...                                                  ...     ...        ...   \n443825  COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443826  COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       3  1.8682407   \n443827  COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443828  COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n443829  COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1       4  1.8682407   \n\n       precursor_type  ...             drugcentral_synonyms  \\\n741            [M+H]+  ...  icotinib,icotinib hydrochloride   \n742            [M+H]+  ...  icotinib,icotinib hydrochloride   \n743            [M+H]+  ...  icotinib,icotinib hydrochloride   \n744            [M+H]+  ...  icotinib,icotinib hydrochloride   \n745            [M+H]+  ...  icotinib,icotinib hydrochloride   \n...               ...  ...                              ...   \n443825         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443826         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443827         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443828         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n443829         [M+H]+  ...  gefitinib,iressa,ZD 1839,ZD1839   \n\n       drugcentral_pharma_type  \\\n741                        NaN   \n742                        NaN   \n743                        NaN   \n744                        NaN   \n745                        NaN   \n...                        ...   \n443825     EPC,has role,MoA,PA   \n443826     EPC,has role,MoA,PA   \n443827     EPC,has role,MoA,PA   \n443828     EPC,has role,MoA,PA   \n443829     EPC,has role,MoA,PA   \n\n                                 drugcentral_pharma_class drugcentral_atc  \\\n741                                                   NaN         L01EB08   \n742                                                   NaN         L01EB08   \n743                                                   NaN         L01EB08   \n744                                                   NaN         L01EB08   \n745                                                   NaN         L01EB08   \n...                                                   ...             ...   \n443825  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443826  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443827  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443828  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n443829  antineoplastic agents,Antineoplastic Agents,EG...         L01EB01   \n\n       drugcentral_dosage drugbank_approved_number  \\\n741                   NaN                      NaN   \n742                   NaN                      NaN   \n743                   NaN                      NaN   \n744                   NaN                      NaN   \n745                   NaN                      NaN   \n...                   ...                      ...   \n443825              250mg                      4.0   \n443826              250mg                      4.0   \n443827              250mg                      4.0   \n443828              250mg                      4.0   \n443829              250mg                      4.0   \n\n       drugcentral_administration_number any_phase  none lib_plate_well_unique  \n741                                  4.0      True  13.0   pluskal_mce_1D1_I1.  \n742                                  4.0      True  13.0   pluskal_mce_1D1_I1.  \n743                                  4.0      True  13.0   pluskal_mce_1D1_I1.  \n744                                  4.0      True  13.0   pluskal_mce_1D1_I1.  \n745                                  4.0      True  13.0   pluskal_mce_1D1_I1.  \n...                                  ...       ...   ...                   ...  \n443825                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443826                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443827                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443828                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n443829                               4.0      True   5.0  pluskal_mce_1D3_J24.  \n\n[94827 rows x 132 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>741</th>\n      <td>Icotinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>391.153206</td>\n      <td>C22H21N3O4</td>\n      <td>InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...</td>\n      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>\n      <td>C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1</td>\n      <td>2</td>\n      <td>1.1265261</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>icotinib,icotinib hydrochloride</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>L01EB08</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>13.0</td>\n      <td>pluskal_mce_1D1_I1.</td>\n    </tr>\n    <tr>\n      <th>742</th>\n      <td>Icotinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>391.153206</td>\n      <td>C22H21N3O4</td>\n      <td>InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...</td>\n      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>\n      <td>C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1</td>\n      <td>2</td>\n      <td>1.1265261</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>icotinib,icotinib hydrochloride</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>L01EB08</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>13.0</td>\n      <td>pluskal_mce_1D1_I1.</td>\n    </tr>\n    <tr>\n      <th>743</th>\n      <td>Icotinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>391.153206</td>\n      <td>C22H21N3O4</td>\n      <td>InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...</td>\n      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>\n      <td>C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1</td>\n      <td>2</td>\n      <td>1.1265261</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>icotinib,icotinib hydrochloride</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>L01EB08</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>13.0</td>\n      <td>pluskal_mce_1D1_I1.</td>\n    </tr>\n    <tr>\n      <th>744</th>\n      <td>Icotinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>391.153206</td>\n      <td>C22H21N3O4</td>\n      <td>InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...</td>\n      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>\n      <td>C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1</td>\n      <td>2</td>\n      <td>1.1265261</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>icotinib,icotinib hydrochloride</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>L01EB08</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>13.0</td>\n      <td>pluskal_mce_1D1_I1.</td>\n    </tr>\n    <tr>\n      <th>745</th>\n      <td>Icotinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>391.153206</td>\n      <td>C22H21N3O4</td>\n      <td>InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-...</td>\n      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>\n      <td>C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1</td>\n      <td>2</td>\n      <td>1.1265261</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>icotinib,icotinib hydrochloride</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>L01EB08</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>13.0</td>\n      <td>pluskal_mce_1D1_I1.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>443825</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443826</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>3</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443827</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443828</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n    <tr>\n      <th>443829</th>\n      <td>Gefitinib</td>\n      <td>MCE bioactive compounds library</td>\n      <td>446.152097</td>\n      <td>C22H24ClFN4O3</td>\n      <td>InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21...</td>\n      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>\n      <td>COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1</td>\n      <td>4</td>\n      <td>1.8682407</td>\n      <td>[M+H]+</td>\n      <td>...</td>\n      <td>gefitinib,iressa,ZD 1839,ZD1839</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>antineoplastic agents,Antineoplastic Agents,EG...</td>\n      <td>L01EB01</td>\n      <td>250mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>5.0</td>\n      <td>pluskal_mce_1D3_J24.</td>\n    </tr>\n  </tbody>\n</table>\n<p>94827 rows × 132 columns</p>\n</div>"
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "approved_df = df[df[\"clinical_phase\"]==4]\n",
    "approved_df"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "outputs": [
    {
     "data": {
      "text/plain": "                             name  description  exactmass  formula_x  inchi_x  \\\ninchi_key_x                                                                     \nAAKJLRGGTJKAMG-UHFFFAOYSA-N   119          119        119        119      119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N    73           73         73         73       73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N   169          169        169        169      169   \nACEWLPOYLGNNHV-UHFFFAOYSA-N   129          129        129        129      129   \nACGDKVXYNVEAGU-UHFFFAOYSA-N    17           17         17         17       17   \n...                           ...          ...        ...        ...      ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N   152          152        152        152      152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N    17           17         17         17       17   \nZXVNMYWKKDOREA-UHFFFAOYSA-N    49           49         49         49       49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N    66           66         66         66       66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N    87           87         87         87       87   \n\n                             inchiaux  smiles  mslevel   rt  precursor_type  \\\ninchi_key_x                                                                   \nAAKJLRGGTJKAMG-UHFFFAOYSA-N       119     119      119  119             119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N        73      73       73   73              73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N       169     169      169  169             169   \nACEWLPOYLGNNHV-UHFFFAOYSA-N       129     129      129  129             129   \nACGDKVXYNVEAGU-UHFFFAOYSA-N        17      17       17   17              17   \n...                               ...     ...      ...  ...             ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N       152     152      152  152             152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N        17      17       17   17              17   \nZXVNMYWKKDOREA-UHFFFAOYSA-N        49      49       49   49              49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N        66      66       66   66              66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N        87      87       87   87              87   \n\n                             ...  drugcentral_synonyms  \\\ninchi_key_x                  ...                         \nAAKJLRGGTJKAMG-UHFFFAOYSA-N  ...                   119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N  ...                    73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N  ...                   169   \nACEWLPOYLGNNHV-UHFFFAOYSA-N  ...                   129   \nACGDKVXYNVEAGU-UHFFFAOYSA-N  ...                    17   \n...                          ...                   ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N  ...                   152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N  ...                    17   \nZXVNMYWKKDOREA-UHFFFAOYSA-N  ...                    49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N  ...                    66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N  ...                    87   \n\n                             drugcentral_pharma_type  \\\ninchi_key_x                                            \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                      119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N                       73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N                        0   \nACEWLPOYLGNNHV-UHFFFAOYSA-N                      129   \nACGDKVXYNVEAGU-UHFFFAOYSA-N                       17   \n...                                              ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N                      152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N                       17   \nZXVNMYWKKDOREA-UHFFFAOYSA-N                       49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                       66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                       87   \n\n                             drugcentral_pharma_class  drugcentral_atc  \\\ninchi_key_x                                                              \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                       119              119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N                        73               73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N                         0              169   \nACEWLPOYLGNNHV-UHFFFAOYSA-N                       129                0   \nACGDKVXYNVEAGU-UHFFFAOYSA-N                        17               17   \n...                                               ...              ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N                       152              152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N                        17               17   \nZXVNMYWKKDOREA-UHFFFAOYSA-N                        49               49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                        66               66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                        87               87   \n\n                             drugcentral_dosage  drugbank_approved_number  \\\ninchi_key_x                                                                 \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                 119                       119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N                  73                        73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N                   0                       169   \nACEWLPOYLGNNHV-UHFFFAOYSA-N                   0                         0   \nACGDKVXYNVEAGU-UHFFFAOYSA-N                   0                        17   \n...                                         ...                       ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N                   0                       152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N                   0                         0   \nZXVNMYWKKDOREA-UHFFFAOYSA-N                   0                        49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                   0                        66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                   0                        87   \n\n                             drugcentral_administration_number  any_phase  \\\ninchi_key_x                                                                 \nAAKJLRGGTJKAMG-UHFFFAOYSA-N                                119        119   \nABJKWBDEJIDSJZ-UHFFFAOYSA-N                                 73         73   \nACCMWZWAEFYUGZ-UHFFFAOYSA-N                                169        169   \nACEWLPOYLGNNHV-UHFFFAOYSA-N                                  0        129   \nACGDKVXYNVEAGU-UHFFFAOYSA-N                                 17         17   \n...                                                        ...        ...   \nZXIBCJHYVWYIKI-PZJWPPBQSA-N                                152        152   \nZXNRTKGTQJPIJK-UHFFFAOYSA-N                                  0         17   \nZXVNMYWKKDOREA-UHFFFAOYSA-N                                  0         49   \nZZHLYYDVIOPZBE-UHFFFAOYSA-N                                 66         66   \nZZORFUFYDOWNEF-UHFFFAOYSA-N                                  0         87   \n\n                             none  lib_plate_well_unique  \ninchi_key_x                                               \nAAKJLRGGTJKAMG-UHFFFAOYSA-N   119                    119  \nABJKWBDEJIDSJZ-UHFFFAOYSA-N    73                     73  \nACCMWZWAEFYUGZ-UHFFFAOYSA-N   169                    169  \nACEWLPOYLGNNHV-UHFFFAOYSA-N   129                    129  \nACGDKVXYNVEAGU-UHFFFAOYSA-N    17                     17  \n...                           ...                    ...  \nZXIBCJHYVWYIKI-PZJWPPBQSA-N   152                    152  \nZXNRTKGTQJPIJK-UHFFFAOYSA-N    17                     17  \nZXVNMYWKKDOREA-UHFFFAOYSA-N    49                     49  \nZZHLYYDVIOPZBE-UHFFFAOYSA-N    66                     66  \nZZORFUFYDOWNEF-UHFFFAOYSA-N    87                     87  \n\n[1523 rows x 131 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n    <tr>\n      <th>inchi_key_x</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>AAKJLRGGTJKAMG-UHFFFAOYSA-N</th>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>...</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n      <td>119</td>\n    </tr>\n    <tr>\n      <th>ABJKWBDEJIDSJZ-UHFFFAOYSA-N</th>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>...</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n      <td>73</td>\n    </tr>\n    <tr>\n      <th>ACCMWZWAEFYUGZ-UHFFFAOYSA-N</th>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>...</td>\n      <td>169</td>\n      <td>0</td>\n      <td>0</td>\n      <td>169</td>\n      <td>0</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n      <td>169</td>\n    </tr>\n    <tr>\n      <th>ACEWLPOYLGNNHV-UHFFFAOYSA-N</th>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>...</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n    </tr>\n    <tr>\n      <th>ACGDKVXYNVEAGU-UHFFFAOYSA-N</th>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>...</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>0</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>ZXIBCJHYVWYIKI-PZJWPPBQSA-N</th>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>...</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>0</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n      <td>152</td>\n    </tr>\n    <tr>\n      <th>ZXNRTKGTQJPIJK-UHFFFAOYSA-N</th>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>...</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n    </tr>\n    <tr>\n      <th>ZXVNMYWKKDOREA-UHFFFAOYSA-N</th>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>...</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>0</td>\n      <td>49</td>\n      <td>0</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n    </tr>\n    <tr>\n      <th>ZZHLYYDVIOPZBE-UHFFFAOYSA-N</th>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>...</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>0</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n      <td>66</td>\n    </tr>\n    <tr>\n      <th>ZZORFUFYDOWNEF-UHFFFAOYSA-N</th>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>...</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n      <td>0</td>\n      <td>87</td>\n      <td>0</td>\n      <td>87</td>\n      <td>87</td>\n      <td>87</td>\n    </tr>\n  </tbody>\n</table>\n<p>1523 rows × 131 columns</p>\n</div>"
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "approved_df.groupby(\"inchi_key_x\").count()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "outputs": [
    {
     "data": {
      "text/plain": "                   description  exactmass  formula_x  inchi_x  inchiaux  \\\nname                                                                      \n(+)-Ajmaline               104        104        104      104       104   \n(+)-Penbutolol              47         47         47       47        47   \n(+)-Tetrabenazine          116        116        116      116       116   \n(+)-catechin                11         11         11       11        11   \n(-)-Epicatechin             54         54         54       54        54   \n...                        ...        ...        ...      ...       ...   \nxylometazoline              72         72         72       72        72   \nzafirlukast                 27         27         27       27        27   \nzalcitabine                 17         17         17       17        17   \nzanamivir                   29         29         29       29        29   \nzomepirac                   49         49         49       49        49   \n\n                   smiles  mslevel   rt  precursor_type  pepmass  ...  \\\nname                                                              ...   \n(+)-Ajmaline          104      104  104             104      104  ...   \n(+)-Penbutolol         47       47   47              47       47  ...   \n(+)-Tetrabenazine     116      116  116             116      116  ...   \n(+)-catechin           11       11   11              11       11  ...   \n(-)-Epicatechin        54       54   54              54       54  ...   \n...                   ...      ...  ...             ...      ...  ...   \nxylometazoline         72       72   72              72       72  ...   \nzafirlukast            27       27   27              27       27  ...   \nzalcitabine            17       17   17              17       17  ...   \nzanamivir              29       29   29              29       29  ...   \nzomepirac              49       49   49              49       49  ...   \n\n                   drugcentral_synonyms  drugcentral_pharma_type  \\\nname                                                               \n(+)-Ajmaline                        104                      104   \n(+)-Penbutolol                       47                       47   \n(+)-Tetrabenazine                   116                      116   \n(+)-catechin                         11                       11   \n(-)-Epicatechin                      54                       54   \n...                                 ...                      ...   \nxylometazoline                       72                       72   \nzafirlukast                          27                       27   \nzalcitabine                          17                       17   \nzanamivir                            29                       29   \nzomepirac                            49                       49   \n\n                   drugcentral_pharma_class  drugcentral_atc  \\\nname                                                           \n(+)-Ajmaline                            104              104   \n(+)-Penbutolol                           47               47   \n(+)-Tetrabenazine                       116              116   \n(+)-catechin                             11                0   \n(-)-Epicatechin                          54                0   \n...                                     ...              ...   \nxylometazoline                           72               72   \nzafirlukast                              27               27   \nzalcitabine                              17               17   \nzanamivir                                29               29   \nzomepirac                                49               49   \n\n                   drugcentral_dosage  drugbank_approved_number  \\\nname                                                              \n(+)-Ajmaline                        0                       104   \n(+)-Penbutolol                      0                        47   \n(+)-Tetrabenazine                 116                       116   \n(+)-catechin                       11                        11   \n(-)-Epicatechin                    54                         0   \n...                               ...                       ...   \nxylometazoline                     72                        72   \nzafirlukast                        27                        27   \nzalcitabine                         0                        17   \nzanamivir                          29                        29   \nzomepirac                           0                        49   \n\n                   drugcentral_administration_number  any_phase  none  \\\nname                                                                    \n(+)-Ajmaline                                       0        104   104   \n(+)-Penbutolol                                    47         47    47   \n(+)-Tetrabenazine                                116        116   116   \n(+)-catechin                                      11         11    11   \n(-)-Epicatechin                                   54         54    54   \n...                                              ...        ...   ...   \nxylometazoline                                    72         72    72   \nzafirlukast                                       27         27    27   \nzalcitabine                                       17         17    17   \nzanamivir                                         29         29    29   \nzomepirac                                          0         49    49   \n\n                   lib_plate_well_unique  \nname                                      \n(+)-Ajmaline                         104  \n(+)-Penbutolol                        47  \n(+)-Tetrabenazine                    116  \n(+)-catechin                          11  \n(-)-Epicatechin                       54  \n...                                  ...  \nxylometazoline                        72  \nzafirlukast                           27  \nzalcitabine                           17  \nzanamivir                             29  \nzomepirac                             49  \n\n[1520 rows x 131 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>pepmass</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n    <tr>\n      <th>name</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>(+)-Ajmaline</th>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>...</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n      <td>0</td>\n      <td>104</td>\n      <td>0</td>\n      <td>104</td>\n      <td>104</td>\n      <td>104</td>\n    </tr>\n    <tr>\n      <th>(+)-Penbutolol</th>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>...</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>0</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n      <td>47</td>\n    </tr>\n    <tr>\n      <th>(+)-Tetrabenazine</th>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>...</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n      <td>116</td>\n    </tr>\n    <tr>\n      <th>(+)-catechin</th>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>...</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>0</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n      <td>11</td>\n    </tr>\n    <tr>\n      <th>(-)-Epicatechin</th>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>...</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>0</td>\n      <td>54</td>\n      <td>0</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n      <td>54</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>xylometazoline</th>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>...</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n      <td>72</td>\n    </tr>\n    <tr>\n      <th>zafirlukast</th>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>...</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n      <td>27</td>\n    </tr>\n    <tr>\n      <th>zalcitabine</th>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>...</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>0</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n      <td>17</td>\n    </tr>\n    <tr>\n      <th>zanamivir</th>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>...</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n      <td>29</td>\n    </tr>\n    <tr>\n      <th>zomepirac</th>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>...</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n      <td>0</td>\n      <td>49</td>\n      <td>0</td>\n      <td>49</td>\n      <td>49</td>\n      <td>49</td>\n    </tr>\n  </tbody>\n</table>\n<p>1520 rows × 131 columns</p>\n</div>"
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "approved_df.groupby(\"name\").count()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "outputs": [
    {
     "data": {
      "text/plain": "                     name  description  exactmass  formula_x  inchi_x  \\\nlib_plate_well                                                          \npluskal_mce_1D1_A1    800          800        800        800      800   \npluskal_mce_1D1_A10  1312         1312       1312       1312     1312   \npluskal_mce_1D1_A11  2085         2085       2085       2085     2085   \npluskal_mce_1D1_A12  1356         1356       1356       1356     1356   \npluskal_mce_1D1_A13  1386         1386       1386       1386     1386   \n...                   ...          ...        ...        ...      ...   \npluskal_mce_1D3_L5    543          543        543        543      543   \npluskal_mce_1D3_L6    549          549        549        549      549   \npluskal_mce_1D3_L7    332          332        332        332      332   \npluskal_mce_1D3_L8    299          299        299        299      299   \npluskal_mce_1D3_L9    200          200        200        200      200   \n\n                     inchiaux  smiles  mslevel    rt  precursor_type  ...  \\\nlib_plate_well                                                        ...   \npluskal_mce_1D1_A1        800     800      800   800             800  ...   \npluskal_mce_1D1_A10      1312    1312     1312  1312            1312  ...   \npluskal_mce_1D1_A11      2085    2085     2085  2085            2085  ...   \npluskal_mce_1D1_A12      1356    1356     1356  1356            1356  ...   \npluskal_mce_1D1_A13      1386    1386     1386  1386            1386  ...   \n...                       ...     ...      ...   ...             ...  ...   \npluskal_mce_1D3_L5        543     543      543   543             543  ...   \npluskal_mce_1D3_L6        549     549      549   549             549  ...   \npluskal_mce_1D3_L7        332     332      332   332             332  ...   \npluskal_mce_1D3_L8        299     299      299   299             299  ...   \npluskal_mce_1D3_L9        200     200      200   200             200  ...   \n\n                     drugcentral_synonyms  drugcentral_pharma_type  \\\nlib_plate_well                                                       \npluskal_mce_1D1_A1                     30                       30   \npluskal_mce_1D1_A10                   310                      310   \npluskal_mce_1D1_A11                     0                        0   \npluskal_mce_1D1_A12                     0                        0   \npluskal_mce_1D1_A13                   251                      251   \n...                                   ...                      ...   \npluskal_mce_1D3_L5                    110                      110   \npluskal_mce_1D3_L6                    123                       59   \npluskal_mce_1D3_L7                    138                      138   \npluskal_mce_1D3_L8                     60                       60   \npluskal_mce_1D3_L9                      0                        0   \n\n                     drugcentral_pharma_class  drugcentral_atc  \\\nlib_plate_well                                                   \npluskal_mce_1D1_A1                         30               30   \npluskal_mce_1D1_A10                       310              310   \npluskal_mce_1D1_A11                         0                0   \npluskal_mce_1D1_A12                         0                0   \npluskal_mce_1D1_A13                       251              251   \n...                                       ...              ...   \npluskal_mce_1D3_L5                        110              110   \npluskal_mce_1D3_L6                         59               59   \npluskal_mce_1D3_L7                        138               58   \npluskal_mce_1D3_L8                         60                0   \npluskal_mce_1D3_L9                          0                0   \n\n                     drugcentral_dosage  drugbank_approved_number  \\\nlib_plate_well                                                      \npluskal_mce_1D1_A1                   30                        30   \npluskal_mce_1D1_A10                 129                       129   \npluskal_mce_1D1_A11                   0                         0   \npluskal_mce_1D1_A12                   0                         0   \npluskal_mce_1D1_A13                 251                       251   \n...                                 ...                       ...   \npluskal_mce_1D3_L5                  110                       110   \npluskal_mce_1D3_L6                   59                        59   \npluskal_mce_1D3_L7                   89                        89   \npluskal_mce_1D3_L8                    0                         0   \npluskal_mce_1D3_L9                    0                         0   \n\n                     drugcentral_administration_number  any_phase  none  \\\nlib_plate_well                                                            \npluskal_mce_1D1_A1                                  30        782   782   \npluskal_mce_1D1_A10                                129       1312  1312   \npluskal_mce_1D1_A11                                  0       1965  1965   \npluskal_mce_1D1_A12                                  0       1356  1356   \npluskal_mce_1D1_A13                                251       1386  1386   \n...                                                ...        ...   ...   \npluskal_mce_1D3_L5                                 110        509   509   \npluskal_mce_1D3_L6                                  59        521   521   \npluskal_mce_1D3_L7                                  89        332   332   \npluskal_mce_1D3_L8                                   0        278   278   \npluskal_mce_1D3_L9                                   0        200   200   \n\n                     lib_plate_well_unique  \nlib_plate_well                              \npluskal_mce_1D1_A1                     782  \npluskal_mce_1D1_A10                   1312  \npluskal_mce_1D1_A11                   1965  \npluskal_mce_1D1_A12                   1356  \npluskal_mce_1D1_A13                   1386  \n...                                    ...  \npluskal_mce_1D3_L5                     509  \npluskal_mce_1D3_L6                     521  \npluskal_mce_1D3_L7                     332  \npluskal_mce_1D3_L8                     278  \npluskal_mce_1D3_L9                     200  \n\n[1042 rows x 131 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n    <tr>\n      <th>lib_plate_well</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>pluskal_mce_1D1_A1</th>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>800</td>\n      <td>...</td>\n      <td>30</td>\n      <td>30</td>\n      <td>30</td>\n      <td>30</td>\n      <td>30</td>\n      <td>30</td>\n      <td>30</td>\n      <td>782</td>\n      <td>782</td>\n      <td>782</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D1_A10</th>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>...</td>\n      <td>310</td>\n      <td>310</td>\n      <td>310</td>\n      <td>310</td>\n      <td>129</td>\n      <td>129</td>\n      <td>129</td>\n      <td>1312</td>\n      <td>1312</td>\n      <td>1312</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D1_A11</th>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>2085</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1965</td>\n      <td>1965</td>\n      <td>1965</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D1_A12</th>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>1356</td>\n      <td>1356</td>\n      <td>1356</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D1_A13</th>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>...</td>\n      <td>251</td>\n      <td>251</td>\n      <td>251</td>\n      <td>251</td>\n      <td>251</td>\n      <td>251</td>\n      <td>251</td>\n      <td>1386</td>\n      <td>1386</td>\n      <td>1386</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D3_L5</th>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>543</td>\n      <td>...</td>\n      <td>110</td>\n      <td>110</td>\n      <td>110</td>\n      <td>110</td>\n      <td>110</td>\n      <td>110</td>\n      <td>110</td>\n      <td>509</td>\n      <td>509</td>\n      <td>509</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D3_L6</th>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>549</td>\n      <td>...</td>\n      <td>123</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>59</td>\n      <td>521</td>\n      <td>521</td>\n      <td>521</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D3_L7</th>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n      <td>...</td>\n      <td>138</td>\n      <td>138</td>\n      <td>138</td>\n      <td>58</td>\n      <td>89</td>\n      <td>89</td>\n      <td>89</td>\n      <td>332</td>\n      <td>332</td>\n      <td>332</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D3_L8</th>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>299</td>\n      <td>...</td>\n      <td>60</td>\n      <td>60</td>\n      <td>60</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>278</td>\n      <td>278</td>\n      <td>278</td>\n    </tr>\n    <tr>\n      <th>pluskal_mce_1D3_L9</th>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>200</td>\n      <td>200</td>\n      <td>200</td>\n    </tr>\n  </tbody>\n</table>\n<p>1042 rows × 131 columns</p>\n</div>"
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.groupby(\"lib_plate_well\").count()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "outputs": [
    {
     "data": {
      "text/plain": "<Figure size 432x432 with 3 Axes>",
      "image/png": "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\n"
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df[\"quality_explained_intensity\"] = df[\"quality_explained_intensity\"].astype(\"float\")\n",
    "df[\"num peaks\"] = df[\"num peaks\"].astype(\"int\")\n",
    "df[\"quality_explained_signals\"] = df[\"quality_explained_signals\"].astype(\"float\")\n",
    "ax = sns.jointplot(data=df[df[\"num peaks\"]< 500], x=\"quality_explained_intensity\", y=\"num peaks\", kind=\"hist\", ratio=2)\n",
    "ax.set_axis_labels(\"Explained Intensity\", \"Number of Peaks\")\n",
    "plt.savefig(\"figures/mce_msn_library/data_quality_msn.png\", dpi=300)"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "outputs": [],
   "source": [
    "def save_fig(file_name):\n",
    "    plt.savefig(\"figures/mce_msn_library/{}.png\".format(file_name), dpi=300)\n",
    "    plt.savefig(\"figures/mce_msn_library/{}.pdf\".format(file_name))\n",
    "    plt.savefig(\"figures/mce_msn_library/{}.svg\".format(file_name))\n",
    "\n",
    "sns.set_theme(font_scale=2, style=\"ticks\")"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "outputs": [
    {
     "data": {
      "text/plain": "<Figure size 936x648 with 1 Axes>",
      "image/png": "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\n"
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "file_name = \"explained_intensity\"\n",
    "\n",
    "plt.figure(figsize=(13, 9))\n",
    "ax = sns.histplot(data=df, x=\"quality_explained_intensity\", binwidth=0.02, kde=False)\n",
    "# ax.set_xlim(0,2000)\n",
    "ax.set(xlabel=\"Explained Intensity\")\n",
    "save_fig(file_name)"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "outputs": [
    {
     "data": {
      "text/plain": "<Figure size 936x648 with 1 Axes>",
      "image/png": "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\n"
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "file_name = \"explained_signals\"\n",
    "\n",
    "plt.figure(figsize=(13, 9))\n",
    "ax = sns.histplot(data=df, x=\"quality_explained_signals\", binwidth=0.02, kde=False)\n",
    "# ax.set_xlim(0,2000)\n",
    "ax.set(xlabel=\"Explained Signals\")\n",
    "save_fig(file_name)"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "outputs": [
    {
     "data": {
      "text/plain": "<Figure size 936x648 with 1 Axes>",
      "image/png": "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\n"
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "file_name = \"number_of_signals\"\n",
    "\n",
    "plt.figure(figsize=(13, 9))\n",
    "ax = sns.histplot(data=df, x=\"num peaks\", binwidth=1, kde=False)\n",
    "ax.set_xlim(0,50)\n",
    "ax.set(xlabel=\"Number of Signals\")\n",
    "save_fig(file_name)"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "outputs": [
    {
     "data": {
      "text/plain": "                      name  description  exactmass  formula_x  inchi_x  \\\nquality_chimeric                                                         \nCHIMERIC               970          970        970        970      970   \nMISSING_MAIN_SIGNAL     42           42         42         42       42   \nPASSED               11972        11972      11972      11972    11972   \n\n                     inchiaux  smiles  mslevel     rt  precursor_type  ...  \\\nquality_chimeric                                                       ...   \nCHIMERIC                  970     970      970    970             970  ...   \nMISSING_MAIN_SIGNAL        42      42       42     42              42  ...   \nPASSED                  11972   11972    11972  11972           11972  ...   \n\n                     drugcentral_synonyms  drugcentral_pharma_type  \\\nquality_chimeric                                                     \nCHIMERIC                                0                        0   \nMISSING_MAIN_SIGNAL                     0                        0   \nPASSED                               2645                     2356   \n\n                     drugcentral_pharma_class  drugcentral_atc  \\\nquality_chimeric                                                 \nCHIMERIC                                    0                0   \nMISSING_MAIN_SIGNAL                         0                0   \nPASSED                                   2356             2043   \n\n                     drugcentral_dosage  drugbank_approved_number  \\\nquality_chimeric                                                    \nCHIMERIC                              0                         0   \nMISSING_MAIN_SIGNAL                   0                         0   \nPASSED                             1562                      1881   \n\n                     drugcentral_administration_number  any_phase   none  \\\nquality_chimeric                                                           \nCHIMERIC                                             0          0      0   \nMISSING_MAIN_SIGNAL                                  0         42     42   \nPASSED                                            2020      11972  11972   \n\n                     lib_plate_well_unique  \nquality_chimeric                            \nCHIMERIC                                 0  \nMISSING_MAIN_SIGNAL                     42  \nPASSED                               11972  \n\n[3 rows x 131 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>name</th>\n      <th>description</th>\n      <th>exactmass</th>\n      <th>formula_x</th>\n      <th>inchi_x</th>\n      <th>inchiaux</th>\n      <th>smiles</th>\n      <th>mslevel</th>\n      <th>rt</th>\n      <th>precursor_type</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n    <tr>\n      <th>quality_chimeric</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>CHIMERIC</th>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>970</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n    </tr>\n    <tr>\n      <th>MISSING_MAIN_SIGNAL</th>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n      <td>...</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>0</td>\n      <td>42</td>\n      <td>42</td>\n      <td>42</td>\n    </tr>\n    <tr>\n      <th>PASSED</th>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>...</td>\n      <td>2645</td>\n      <td>2356</td>\n      <td>2356</td>\n      <td>2043</td>\n      <td>1562</td>\n      <td>1881</td>\n      <td>2020</td>\n      <td>11972</td>\n      <td>11972</td>\n      <td>11972</td>\n    </tr>\n  </tbody>\n</table>\n<p>3 rows × 131 columns</p>\n</div>"
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df[\"quality_explained_intensity\"]<0.25].groupby(\"quality_chimeric\").count()"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "file = r\"C:\\git\\msn_library\\data\\final_tables\\gnps_phase.tsv\"\n",
    "df = pd.read_csv(file, sep=\"\\t\")\n",
    "df[df[\"clinical_phase\"]]"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "outputs": [
    {
     "data": {
      "text/plain": "       Cat. No.                  Product Name  \\\n0      HY-17406                     Tolcapone   \n1      HY-B0023                  Azelnidipine   \n2      HY-B1664                 Iopanoic acid   \n3      HY-B1451     Imidapril (hydrochloride)   \n4      HY-15516                 Sotagliflozin   \n...         ...                           ...   \n2798   HY-30151                   Methoxsalen   \n2799  HY-B0590B             (+)-Tetrabenazine   \n2800   HY-B1403                    Dienestrol   \n2801   HY-13733  Procarbazine (Hydrochloride)   \n2802   HY-14789                  (R)-Elagolix   \n\n                                               synonyms       CAS No.  \\\n0     ['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...   134308-13-7   \n1     ['Azelnidipine', '123524-52-7', 'CS 905', '3-(...   123524-52-7   \n2     ['Iopanoic acid', '96-83-3', 'Iodopanoic acid'...       96-83-3   \n3     ['Imidapril (hydrochloride)', '89396-94-1', 'T...    89396-94-1   \n4     ['Sotagliflozin', '1018899-04-1', 'LX-4211', '...  1018899-04-1   \n...                                                 ...           ...   \n2798  ['Methoxsalen', '298-81-7', '8-Methoxypsoralen...      298-81-7   \n2799  ['(+)-Tetrabenazine', '1026016-83-0', '(+)-TBZ...  1026016-83-0   \n2800  ['Dienestrol', '84-17-3', 'Dienoestrol', 'Dehy...       84-17-3   \n2801  ['Procarbazine (Hydrochloride)', '366-70-1', '...      366-70-1   \n2802  ['(R)-Elagolix', '834153-87-6', 'NBI-56418', '...   834153-87-6   \n\n                                                 Smiles  pubchem_cid  \\\n0          Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1    4659569.0   \n1     CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...      65948.0   \n2                        CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O       3735.0   \n3     CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O...    5485193.0   \n4     CCOc1ccc(Cc2c(Cl)ccc([C@@H]3O[C@H](SC)[C@@H](O...   24831714.0   \n...                                                 ...          ...   \n2798                          COc1c2oc(=O)ccc2cc2c1occ2       4114.0   \n2799  COc1c(OC)cc2c(c1)CCN1C[C@@H](CC(C)C)C(=O)C[C@H]21     667453.0   \n2800             C/C=C(C(=C/C)/c1ccc(O)cc1)\\c1ccc(O)cc1     667476.0   \n2801                          CNNCc1ccc(C(=O)NC(C)C)cc1       9703.0   \n2802  COc1cccc(-c2c(C)n(Cc3c(C(F)(F)F)cccc3F)c(=O)n(...   11250647.0   \n\n                                        isomeric_smiles  \\\n0     CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...   \n1     CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)...   \n2                     CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O   \n3     CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[...   \n4     CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C...   \n...                                                 ...   \n2798                   COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2   \n2799   CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2CC1=O)OC)OC   \n2800      C/C=C(/C(=C/C)/C1=CC=C(C=C1)O)\\C2=CC=C(C=C2)O   \n2801                    CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl   \n2802  CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[...   \n\n                                       canonical_smiles mixed_location_plate1  \\\n0          Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1               1D2_P21   \n1     CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...               1D1_D10   \n2                        CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O               1D1_M21   \n3     CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C...               1D2_O18   \n4       CCOc1ccc(Cc2c(Cl)ccc(C3OC(SC)C(O)C(O)C3O)c2)cc1                1D1_A8   \n...                                                 ...                   ...   \n2798                          COc1c2oc(=O)ccc2cc2c1occ2               1D3_B17   \n2799           COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21               1D1_M22   \n2800                 CC=C(C(=CC)c1ccc(O)cc1)c1ccc(O)cc1                1D2_C6   \n2801                          CNNCc1ccc(C(=O)NC(C)C)cc1                1D2_E7   \n2802  COc1cccc(-c2c(C)n(Cc3c(C(F)(F)F)cccc3F)c(=O)n(...                1D1_D2   \n\n           lib_plate_well  ...  \\\n0     pluskal_mce_1D2_P21  ...   \n1     pluskal_mce_1D1_D10  ...   \n2     pluskal_mce_1D1_M21  ...   \n3     pluskal_mce_1D2_O18  ...   \n4      pluskal_mce_1D1_A8  ...   \n...                   ...  ...   \n2798  pluskal_mce_1D3_B17  ...   \n2799  pluskal_mce_1D1_M22  ...   \n2800   pluskal_mce_1D2_C6  ...   \n2801   pluskal_mce_1D2_E7  ...   \n2802   pluskal_mce_1D1_D2  ...   \n\n                                   drugcentral_synonyms  \\\n0                           RO 40-7592,tasmar,tolcapone   \n1                          azelnidipine,calblock,CS-905   \n2     iodopanic acid,iodopanoic acid,iopanoic acid,i...   \n3     imidapril,imidapril HCl,imidapril hydrochlorid...   \n4      LP-802034,LX-4211,LX4211,sotagliflozin,zynquista   \n...                                                 ...   \n2798  8-Methoxypsoralen,8-Methoxypsoralene,8-MOP,del...   \n2799  (+/-)-Tetrabenazine,choreazine,rubigen,tetrabe...   \n2800  cycladiene,dienesterol,dienestrol,dienoestrol,...   \n2801  ibenzmethyzine,procarbazine,procarbazine HCl,p...   \n2802  BT-620,elagolix,elagolix sodium,NBI-56418,oril...   \n\n        drugcentral_pharma_type  \\\n0           EPC,has role,MoA,PA   \n1                           NaN   \n2                            PA   \n3                   has role,PA   \n4                            PA   \n...                         ...   \n2798  CS,EPC,has role,MoA,PA,PE   \n2799        EPC,has role,MoA,PA   \n2800                has role,PA   \n2801        EPC,has role,MoA,PA   \n2802                 EPC,MoA,PE   \n\n                               drugcentral_pharma_class  drugcentral_atc  \\\n0     Anti-Dyskinesia Agents,antiparkinson agent,Ant...          N04BX01   \n1                                                   NaN              NaN   \n2           Contrast Media,Diagnostic Uses of Chemicals          V08AC06   \n3     ACE inhibitor,Angiotensin-Converting Enzyme In...          C09AA16   \n4     Hypoglycemic Agents,Sodium-Glucose Transporter...          A10BK06   \n...                                                 ...              ...   \n2798  antineoplastic agents,cross-linking reagents,C...  D05AD02,D05BA02   \n2799  Adrenergic Agents,adrenergic uptake inhibitors...          N07XX06   \n2800  Estrogens,Estrogens, Non-Steroidal,Hormones,xe...  G03CB01,G03CC02   \n2801  Alkylating Activity,Alkylating Drug,antineopla...          L01XB01   \n2802  Cytochrome P450 2C19 Inhibitors,Cytochrome P45...          H01CC03   \n\n     drugcentral_dosage drugbank_approved_number  \\\n0                 100mg                      4.0   \n1                   NaN                      NaN   \n2                   NaN                      4.0   \n3                   NaN                      NaN   \n4                   NaN                      4.0   \n...                 ...                      ...   \n2798          10mg,20ug                      4.0   \n2799        12.5mg,25mg                      4.0   \n2800                NaN                      4.0   \n2801               50mg                      4.0   \n2802        150mg,200mg                      4.0   \n\n      drugcentral_administration_number any_phase none lib_plate_well_unique  \n0                                   4.0      True    3  pluskal_mce_1D2_P21.  \n1                                   NaN      True   23  pluskal_mce_1D1_D10.  \n2                                   4.0      True   22  pluskal_mce_1D1_M21.  \n3                                   4.0      True   22  pluskal_mce_1D2_O18.  \n4                                   4.0      True   22   pluskal_mce_1D1_A8.  \n...                                 ...       ...  ...                   ...  \n2798                                4.0      True   10  pluskal_mce_1D3_B17.  \n2799                                4.0      True    9  pluskal_mce_1D1_M22.  \n2800                                4.0      True   10   pluskal_mce_1D2_C6.  \n2801                                4.0      True   10   pluskal_mce_1D2_E7.  \n2802                                4.0      True    9   pluskal_mce_1D1_D2.  \n\n[2803 rows x 97 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>lib_plate_well</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>HY-17406</td>\n      <td>Tolcapone</td>\n      <td>['Tolcapone', '134308-13-7', 'Ro 40-7592', 'Ta...</td>\n      <td>134308-13-7</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>4659569.0</td>\n      <td>CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)...</td>\n      <td>Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1</td>\n      <td>1D2_P21</td>\n      <td>pluskal_mce_1D2_P21</td>\n      <td>...</td>\n      <td>RO 40-7592,tasmar,tolcapone</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Anti-Dyskinesia Agents,antiparkinson agent,Ant...</td>\n      <td>N04BX01</td>\n      <td>100mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>3</td>\n      <td>pluskal_mce_1D2_P21.</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>HY-B0023</td>\n      <td>Azelnidipine</td>\n      <td>['Azelnidipine', '123524-52-7', 'CS 905', '3-(...</td>\n      <td>123524-52-7</td>\n      <td>CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...</td>\n      <td>65948.0</td>\n      <td>CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)...</td>\n      <td>CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C...</td>\n      <td>1D1_D10</td>\n      <td>pluskal_mce_1D1_D10</td>\n      <td>...</td>\n      <td>azelnidipine,calblock,CS-905</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>23</td>\n      <td>pluskal_mce_1D1_D10.</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>HY-B1664</td>\n      <td>Iopanoic acid</td>\n      <td>['Iopanoic acid', '96-83-3', 'Iodopanoic acid'...</td>\n      <td>96-83-3</td>\n      <td>CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O</td>\n      <td>3735.0</td>\n      <td>CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O</td>\n      <td>CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O</td>\n      <td>1D1_M21</td>\n      <td>pluskal_mce_1D1_M21</td>\n      <td>...</td>\n      <td>iodopanic acid,iodopanoic acid,iopanoic acid,i...</td>\n      <td>PA</td>\n      <td>Contrast Media,Diagnostic Uses of Chemicals</td>\n      <td>V08AC06</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D1_M21.</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>HY-B1451</td>\n      <td>Imidapril (hydrochloride)</td>\n      <td>['Imidapril (hydrochloride)', '89396-94-1', 'T...</td>\n      <td>89396-94-1</td>\n      <td>CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O...</td>\n      <td>5485193.0</td>\n      <td>CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[...</td>\n      <td>CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C...</td>\n      <td>1D2_O18</td>\n      <td>pluskal_mce_1D2_O18</td>\n      <td>...</td>\n      <td>imidapril,imidapril HCl,imidapril hydrochlorid...</td>\n      <td>has role,PA</td>\n      <td>ACE inhibitor,Angiotensin-Converting Enzyme In...</td>\n      <td>C09AA16</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D2_O18.</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>HY-15516</td>\n      <td>Sotagliflozin</td>\n      <td>['Sotagliflozin', '1018899-04-1', 'LX-4211', '...</td>\n      <td>1018899-04-1</td>\n      <td>CCOc1ccc(Cc2c(Cl)ccc([C@@H]3O[C@H](SC)[C@@H](O...</td>\n      <td>24831714.0</td>\n      <td>CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C...</td>\n      <td>CCOc1ccc(Cc2c(Cl)ccc(C3OC(SC)C(O)C(O)C3O)c2)cc1</td>\n      <td>1D1_A8</td>\n      <td>pluskal_mce_1D1_A8</td>\n      <td>...</td>\n      <td>LP-802034,LX-4211,LX4211,sotagliflozin,zynquista</td>\n      <td>PA</td>\n      <td>Hypoglycemic Agents,Sodium-Glucose Transporter...</td>\n      <td>A10BK06</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D1_A8.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>2798</th>\n      <td>HY-30151</td>\n      <td>Methoxsalen</td>\n      <td>['Methoxsalen', '298-81-7', '8-Methoxypsoralen...</td>\n      <td>298-81-7</td>\n      <td>COc1c2oc(=O)ccc2cc2c1occ2</td>\n      <td>4114.0</td>\n      <td>COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2</td>\n      <td>COc1c2oc(=O)ccc2cc2c1occ2</td>\n      <td>1D3_B17</td>\n      <td>pluskal_mce_1D3_B17</td>\n      <td>...</td>\n      <td>8-Methoxypsoralen,8-Methoxypsoralene,8-MOP,del...</td>\n      <td>CS,EPC,has role,MoA,PA,PE</td>\n      <td>antineoplastic agents,cross-linking reagents,C...</td>\n      <td>D05AD02,D05BA02</td>\n      <td>10mg,20ug</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D3_B17.</td>\n    </tr>\n    <tr>\n      <th>2799</th>\n      <td>HY-B0590B</td>\n      <td>(+)-Tetrabenazine</td>\n      <td>['(+)-Tetrabenazine', '1026016-83-0', '(+)-TBZ...</td>\n      <td>1026016-83-0</td>\n      <td>COc1c(OC)cc2c(c1)CCN1C[C@@H](CC(C)C)C(=O)C[C@H]21</td>\n      <td>667453.0</td>\n      <td>CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2CC1=O)OC)OC</td>\n      <td>COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21</td>\n      <td>1D1_M22</td>\n      <td>pluskal_mce_1D1_M22</td>\n      <td>...</td>\n      <td>(+/-)-Tetrabenazine,choreazine,rubigen,tetrabe...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Adrenergic Agents,adrenergic uptake inhibitors...</td>\n      <td>N07XX06</td>\n      <td>12.5mg,25mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>9</td>\n      <td>pluskal_mce_1D1_M22.</td>\n    </tr>\n    <tr>\n      <th>2800</th>\n      <td>HY-B1403</td>\n      <td>Dienestrol</td>\n      <td>['Dienestrol', '84-17-3', 'Dienoestrol', 'Dehy...</td>\n      <td>84-17-3</td>\n      <td>C/C=C(C(=C/C)/c1ccc(O)cc1)\\c1ccc(O)cc1</td>\n      <td>667476.0</td>\n      <td>C/C=C(/C(=C/C)/C1=CC=C(C=C1)O)\\C2=CC=C(C=C2)O</td>\n      <td>CC=C(C(=CC)c1ccc(O)cc1)c1ccc(O)cc1</td>\n      <td>1D2_C6</td>\n      <td>pluskal_mce_1D2_C6</td>\n      <td>...</td>\n      <td>cycladiene,dienesterol,dienestrol,dienoestrol,...</td>\n      <td>has role,PA</td>\n      <td>Estrogens,Estrogens, Non-Steroidal,Hormones,xe...</td>\n      <td>G03CB01,G03CC02</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D2_C6.</td>\n    </tr>\n    <tr>\n      <th>2801</th>\n      <td>HY-13733</td>\n      <td>Procarbazine (Hydrochloride)</td>\n      <td>['Procarbazine (Hydrochloride)', '366-70-1', '...</td>\n      <td>366-70-1</td>\n      <td>CNNCc1ccc(C(=O)NC(C)C)cc1</td>\n      <td>9703.0</td>\n      <td>CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl</td>\n      <td>CNNCc1ccc(C(=O)NC(C)C)cc1</td>\n      <td>1D2_E7</td>\n      <td>pluskal_mce_1D2_E7</td>\n      <td>...</td>\n      <td>ibenzmethyzine,procarbazine,procarbazine HCl,p...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Alkylating Activity,Alkylating Drug,antineopla...</td>\n      <td>L01XB01</td>\n      <td>50mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D2_E7.</td>\n    </tr>\n    <tr>\n      <th>2802</th>\n      <td>HY-14789</td>\n      <td>(R)-Elagolix</td>\n      <td>['(R)-Elagolix', '834153-87-6', 'NBI-56418', '...</td>\n      <td>834153-87-6</td>\n      <td>COc1cccc(-c2c(C)n(Cc3c(C(F)(F)F)cccc3F)c(=O)n(...</td>\n      <td>11250647.0</td>\n      <td>CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[...</td>\n      <td>COc1cccc(-c2c(C)n(Cc3c(C(F)(F)F)cccc3F)c(=O)n(...</td>\n      <td>1D1_D2</td>\n      <td>pluskal_mce_1D1_D2</td>\n      <td>...</td>\n      <td>BT-620,elagolix,elagolix sodium,NBI-56418,oril...</td>\n      <td>EPC,MoA,PE</td>\n      <td>Cytochrome P450 2C19 Inhibitors,Cytochrome P45...</td>\n      <td>H01CC03</td>\n      <td>150mg,200mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>9</td>\n      <td>pluskal_mce_1D1_D2.</td>\n    </tr>\n  </tbody>\n</table>\n<p>2803 rows × 97 columns</p>\n</div>"
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"data/final_tables/mce_library_all_approved.tsv\", sep=\"\\t\")\n",
    "df"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "outputs": [
    {
     "data": {
      "text/plain": "        Cat. No.                  Product Name  \\\n3       HY-B1451     Imidapril (hydrochloride)   \n58    HY-118861A        Enclomiphene (citrate)   \n68      HY-B1472   Deoxycorticosterone acetate   \n71     HY-14648A         Dexamethasone acetate   \n77      HY-13578                     Brivudine   \n...          ...                           ...   \n2736    HY-B0199         Mycophenolate Mofetil   \n2747    HY-B0983    Hydrocortisone 17-butyrate   \n2787    HY-B0226                 Nitrofurazone   \n2790    HY-B1197                    Amcinonide   \n2801    HY-13733  Procarbazine (Hydrochloride)   \n\n                                               synonyms      CAS No.  \\\n3     ['Imidapril (hydrochloride)', '89396-94-1', 'T...   89396-94-1   \n58    ['Enclomiphene (citrate)', '7599-79-3', '(E)-C...    7599-79-3   \n68    ['Deoxycorticosterone acetate', '56-47-3', '11...      56-47-3   \n71    ['Dexamethasone acetate', '1177-87-3', 'Dexame...    1177-87-3   \n77    ['Brivudine', '69304-47-8', 'Bromovinyldeoxyur...   69304-47-8   \n...                                                 ...          ...   \n2736  ['Mycophenolate Mofetil', '128794-94-5', 'RS 6...  128794-94-5   \n2747  ['Hydrocortisone 17-butyrate', '13609-67-1', '...   13609-67-1   \n2787  ['Nitrofurazone', '59-87-0', 'Nitrofural', 'Fu...      59-87-0   \n2790  ['Amcinonide', '51022-69-6', 'CL-34699', 'Cycl...   51022-69-6   \n2801  ['Procarbazine (Hydrochloride)', '366-70-1', '...     366-70-1   \n\n                                                 Smiles  pubchem_cid  \\\n3     CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O...    5485193.0   \n58      CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1    6420009.0   \n68    CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C...       5952.0   \n71    CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CC...     236702.0   \n77    O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1...     446727.0   \n...                                                 ...          ...   \n2736  COc1c(C/C=C(\\C)CCC(=O)OCCN2CCOCC2)c(O)c2C(=O)O...    5281078.0   \n2747  CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(...      26133.0   \n2787                  NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1    5447130.0   \n2790  CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[...     443958.0   \n2801                          CNNCc1ccc(C(=O)NC(C)C)cc1       9703.0   \n\n                                        isomeric_smiles  \\\n3     CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[...   \n58    CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\\C2=CC=CC=C2)/Cl)...   \n68    CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@...   \n71    C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@...   \n77    C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br...   \n...                                                 ...   \n2736  CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)OCC...   \n2747  CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3...   \n2787              C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N   \n2790  CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@...   \n2801                    CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl   \n\n                                       canonical_smiles mixed_location_plate1  \\\n3     CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C...               1D2_O18   \n58        CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1               1D1_M18   \n68      CC(=O)OCC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C               1D2_K23   \n71    CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)...                1D3_B4   \n77               O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1C=CBr                1D3_H1   \n...                                                 ...                   ...   \n2736  COc1c(CC=C(C)CCC(=O)OCCN2CCOCC2)c(O)c2C(=O)OCc...               1D3_A23   \n2747  CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3...                1D2_E7   \n2787                    NC(=O)NN=Cc1ccc([N+](=O)[O-])o1                1D3_F9   \n2790  CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC1C3CCC4=CC(=O)C...               1D1_I17   \n2801                          CNNCc1ccc(C(=O)NC(C)C)cc1                1D2_E7   \n\n           lib_plate_well  ...  \\\n3     pluskal_mce_1D2_O18  ...   \n58    pluskal_mce_1D1_M18  ...   \n68    pluskal_mce_1D2_K23  ...   \n71     pluskal_mce_1D3_B4  ...   \n77     pluskal_mce_1D3_H1  ...   \n...                   ...  ...   \n2736  pluskal_mce_1D3_A23  ...   \n2747   pluskal_mce_1D2_E7  ...   \n2787   pluskal_mce_1D3_F9  ...   \n2790  pluskal_mce_1D1_I17  ...   \n2801   pluskal_mce_1D2_E7  ...   \n\n                                   drugcentral_synonyms  \\\n3     imidapril,imidapril HCl,imidapril hydrochlorid...   \n58    clomifene,clomifene citrate,clomiphene,Clomiph...   \n68    cortexone acetate,decosteron,decosterone,deoxy...   \n71           decadronal,dexamethasone acetate,neofordex   \n77            brivudin,brivudine,bromovinyldeoxyuridine   \n...                                                 ...   \n2736  linfonex,myclausen,mycophenolate mofetil,mycop...   \n2747  Hydrocortisone 17-butyrate,Hydrocortisone 17al...   \n2787  aldomycin,babrocid,furacilin,furacin,furacine,...   \n2790            amciderm,amcinonid,amcinonide,cyclocort   \n2801  ibenzmethyzine,procarbazine,procarbazine HCl,p...   \n\n     drugcentral_pharma_type  \\\n3                has role,PA   \n58       EPC,has role,MoA,PA   \n68               has role,PA   \n71       EPC,has role,MoA,PA   \n77                        PA   \n...                      ...   \n2736         EPC,has role,PA   \n2747     EPC,has role,MoA,PA   \n2787             has role,PA   \n2790     EPC,has role,MoA,PA   \n2801     EPC,has role,MoA,PA   \n\n                               drugcentral_pharma_class  \\\n3     ACE inhibitor,Angiotensin-Converting Enzyme In...   \n58    anti-estrogenic drug,Estrogen Agonist/Antagoni...   \n68    Homo sapiens metabolite,Hormones,Mineralocorti...   \n71    adrenergic agents,Anti-Inflammatory Agents,ant...   \n77               Anti-Infective Agents,Antiviral Agents   \n...                                                 ...   \n2736  Anti-Bacterial Agents,Anti-Infective Agents,an...   \n2747  allergenic drug,anti-allergic drugs,anti-asthm...   \n2787          Anti-Infective Agents,antibacterial drugs   \n2790  anti-inflammatory drugs,Corticosteroid,Cortico...   \n2801  Alkylating Activity,Alkylating Drug,antineopla...   \n\n                                      drugcentral_atc drugcentral_dosage  \\\n3                                             C09AA16                NaN   \n58                                            G03GB02               50mg   \n68                                                NaN                NaN   \n71                                                NaN                NaN   \n77                                            J05AB15                NaN   \n...                                               ...                ...   \n2736                                              NaN  200mg,250mg,500mg   \n2747                                  D07AB02,D07BB04           1mg,30mg   \n2787  B05CA03,D08AF01,D09AA03,P01CC02,S01AX04,S02AA02                NaN   \n2790                                          D07AC11                1mg   \n2801                                          L01XB01               50mg   \n\n     drugbank_approved_number  drugcentral_administration_number any_phase  \\\n3                         NaN                                4.0      True   \n58                        NaN                                4.0      True   \n68                        4.0                                4.0      True   \n71                        4.0                                4.0      True   \n77                        4.0                                NaN      True   \n...                       ...                                ...       ...   \n2736                      4.0                                4.0      True   \n2747                      4.0                                4.0      True   \n2787                      4.0                                4.0      True   \n2790                      4.0                                4.0      True   \n2801                      4.0                                4.0      True   \n\n     none lib_plate_well_unique  \n3      22  pluskal_mce_1D2_O18.  \n58     24  pluskal_mce_1D1_M18.  \n68     23  pluskal_mce_1D2_K23.  \n71     23   pluskal_mce_1D3_B4.  \n77     23   pluskal_mce_1D3_H1.  \n...   ...                   ...  \n2736   10  pluskal_mce_1D3_A23.  \n2747   10   pluskal_mce_1D2_E7.  \n2787   10   pluskal_mce_1D3_F9.  \n2790    9  pluskal_mce_1D1_I17.  \n2801   10   pluskal_mce_1D2_E7.  \n\n[184 rows x 97 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Cat. No.</th>\n      <th>Product Name</th>\n      <th>synonyms</th>\n      <th>CAS No.</th>\n      <th>Smiles</th>\n      <th>pubchem_cid</th>\n      <th>isomeric_smiles</th>\n      <th>canonical_smiles</th>\n      <th>mixed_location_plate1</th>\n      <th>lib_plate_well</th>\n      <th>...</th>\n      <th>drugcentral_synonyms</th>\n      <th>drugcentral_pharma_type</th>\n      <th>drugcentral_pharma_class</th>\n      <th>drugcentral_atc</th>\n      <th>drugcentral_dosage</th>\n      <th>drugbank_approved_number</th>\n      <th>drugcentral_administration_number</th>\n      <th>any_phase</th>\n      <th>none</th>\n      <th>lib_plate_well_unique</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>3</th>\n      <td>HY-B1451</td>\n      <td>Imidapril (hydrochloride)</td>\n      <td>['Imidapril (hydrochloride)', '89396-94-1', 'T...</td>\n      <td>89396-94-1</td>\n      <td>CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O...</td>\n      <td>5485193.0</td>\n      <td>CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[...</td>\n      <td>CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C...</td>\n      <td>1D2_O18</td>\n      <td>pluskal_mce_1D2_O18</td>\n      <td>...</td>\n      <td>imidapril,imidapril HCl,imidapril hydrochlorid...</td>\n      <td>has role,PA</td>\n      <td>ACE inhibitor,Angiotensin-Converting Enzyme In...</td>\n      <td>C09AA16</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>22</td>\n      <td>pluskal_mce_1D2_O18.</td>\n    </tr>\n    <tr>\n      <th>58</th>\n      <td>HY-118861A</td>\n      <td>Enclomiphene (citrate)</td>\n      <td>['Enclomiphene (citrate)', '7599-79-3', '(E)-C...</td>\n      <td>7599-79-3</td>\n      <td>CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1</td>\n      <td>6420009.0</td>\n      <td>CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\\C2=CC=CC=C2)/Cl)...</td>\n      <td>CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1</td>\n      <td>1D1_M18</td>\n      <td>pluskal_mce_1D1_M18</td>\n      <td>...</td>\n      <td>clomifene,clomifene citrate,clomiphene,Clomiph...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>anti-estrogenic drug,Estrogen Agonist/Antagoni...</td>\n      <td>G03GB02</td>\n      <td>50mg</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>24</td>\n      <td>pluskal_mce_1D1_M18.</td>\n    </tr>\n    <tr>\n      <th>68</th>\n      <td>HY-B1472</td>\n      <td>Deoxycorticosterone acetate</td>\n      <td>['Deoxycorticosterone acetate', '56-47-3', '11...</td>\n      <td>56-47-3</td>\n      <td>CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C...</td>\n      <td>5952.0</td>\n      <td>CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@...</td>\n      <td>CC(=O)OCC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C</td>\n      <td>1D2_K23</td>\n      <td>pluskal_mce_1D2_K23</td>\n      <td>...</td>\n      <td>cortexone acetate,decosteron,decosterone,deoxy...</td>\n      <td>has role,PA</td>\n      <td>Homo sapiens metabolite,Hormones,Mineralocorti...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>23</td>\n      <td>pluskal_mce_1D2_K23.</td>\n    </tr>\n    <tr>\n      <th>71</th>\n      <td>HY-14648A</td>\n      <td>Dexamethasone acetate</td>\n      <td>['Dexamethasone acetate', '1177-87-3', 'Dexame...</td>\n      <td>1177-87-3</td>\n      <td>CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CC...</td>\n      <td>236702.0</td>\n      <td>C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@...</td>\n      <td>CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)...</td>\n      <td>1D3_B4</td>\n      <td>pluskal_mce_1D3_B4</td>\n      <td>...</td>\n      <td>decadronal,dexamethasone acetate,neofordex</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>adrenergic agents,Anti-Inflammatory Agents,ant...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>23</td>\n      <td>pluskal_mce_1D3_B4.</td>\n    </tr>\n    <tr>\n      <th>77</th>\n      <td>HY-13578</td>\n      <td>Brivudine</td>\n      <td>['Brivudine', '69304-47-8', 'Bromovinyldeoxyur...</td>\n      <td>69304-47-8</td>\n      <td>O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1...</td>\n      <td>446727.0</td>\n      <td>C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br...</td>\n      <td>O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1C=CBr</td>\n      <td>1D3_H1</td>\n      <td>pluskal_mce_1D3_H1</td>\n      <td>...</td>\n      <td>brivudin,brivudine,bromovinyldeoxyuridine</td>\n      <td>PA</td>\n      <td>Anti-Infective Agents,Antiviral Agents</td>\n      <td>J05AB15</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>23</td>\n      <td>pluskal_mce_1D3_H1.</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>2736</th>\n      <td>HY-B0199</td>\n      <td>Mycophenolate Mofetil</td>\n      <td>['Mycophenolate Mofetil', '128794-94-5', 'RS 6...</td>\n      <td>128794-94-5</td>\n      <td>COc1c(C/C=C(\\C)CCC(=O)OCCN2CCOCC2)c(O)c2C(=O)O...</td>\n      <td>5281078.0</td>\n      <td>CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)OCC...</td>\n      <td>COc1c(CC=C(C)CCC(=O)OCCN2CCOCC2)c(O)c2C(=O)OCc...</td>\n      <td>1D3_A23</td>\n      <td>pluskal_mce_1D3_A23</td>\n      <td>...</td>\n      <td>linfonex,myclausen,mycophenolate mofetil,mycop...</td>\n      <td>EPC,has role,PA</td>\n      <td>Anti-Bacterial Agents,Anti-Infective Agents,an...</td>\n      <td>NaN</td>\n      <td>200mg,250mg,500mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D3_A23.</td>\n    </tr>\n    <tr>\n      <th>2747</th>\n      <td>HY-B0983</td>\n      <td>Hydrocortisone 17-butyrate</td>\n      <td>['Hydrocortisone 17-butyrate', '13609-67-1', '...</td>\n      <td>13609-67-1</td>\n      <td>CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(...</td>\n      <td>26133.0</td>\n      <td>CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3...</td>\n      <td>CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3...</td>\n      <td>1D2_E7</td>\n      <td>pluskal_mce_1D2_E7</td>\n      <td>...</td>\n      <td>Hydrocortisone 17-butyrate,Hydrocortisone 17al...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>allergenic drug,anti-allergic drugs,anti-asthm...</td>\n      <td>D07AB02,D07BB04</td>\n      <td>1mg,30mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D2_E7.</td>\n    </tr>\n    <tr>\n      <th>2787</th>\n      <td>HY-B0226</td>\n      <td>Nitrofurazone</td>\n      <td>['Nitrofurazone', '59-87-0', 'Nitrofural', 'Fu...</td>\n      <td>59-87-0</td>\n      <td>NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1</td>\n      <td>5447130.0</td>\n      <td>C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N</td>\n      <td>NC(=O)NN=Cc1ccc([N+](=O)[O-])o1</td>\n      <td>1D3_F9</td>\n      <td>pluskal_mce_1D3_F9</td>\n      <td>...</td>\n      <td>aldomycin,babrocid,furacilin,furacin,furacine,...</td>\n      <td>has role,PA</td>\n      <td>Anti-Infective Agents,antibacterial drugs</td>\n      <td>B05CA03,D08AF01,D09AA03,P01CC02,S01AX04,S02AA02</td>\n      <td>NaN</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D3_F9.</td>\n    </tr>\n    <tr>\n      <th>2790</th>\n      <td>HY-B1197</td>\n      <td>Amcinonide</td>\n      <td>['Amcinonide', '51022-69-6', 'CL-34699', 'Cycl...</td>\n      <td>51022-69-6</td>\n      <td>CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[...</td>\n      <td>443958.0</td>\n      <td>CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@...</td>\n      <td>CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC1C3CCC4=CC(=O)C...</td>\n      <td>1D1_I17</td>\n      <td>pluskal_mce_1D1_I17</td>\n      <td>...</td>\n      <td>amciderm,amcinonid,amcinonide,cyclocort</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>anti-inflammatory drugs,Corticosteroid,Cortico...</td>\n      <td>D07AC11</td>\n      <td>1mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>9</td>\n      <td>pluskal_mce_1D1_I17.</td>\n    </tr>\n    <tr>\n      <th>2801</th>\n      <td>HY-13733</td>\n      <td>Procarbazine (Hydrochloride)</td>\n      <td>['Procarbazine (Hydrochloride)', '366-70-1', '...</td>\n      <td>366-70-1</td>\n      <td>CNNCc1ccc(C(=O)NC(C)C)cc1</td>\n      <td>9703.0</td>\n      <td>CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl</td>\n      <td>CNNCc1ccc(C(=O)NC(C)C)cc1</td>\n      <td>1D2_E7</td>\n      <td>pluskal_mce_1D2_E7</td>\n      <td>...</td>\n      <td>ibenzmethyzine,procarbazine,procarbazine HCl,p...</td>\n      <td>EPC,has role,MoA,PA</td>\n      <td>Alkylating Activity,Alkylating Drug,antineopla...</td>\n      <td>L01XB01</td>\n      <td>50mg</td>\n      <td>4.0</td>\n      <td>4.0</td>\n      <td>True</td>\n      <td>10</td>\n      <td>pluskal_mce_1D2_E7.</td>\n    </tr>\n  </tbody>\n</table>\n<p>184 rows × 97 columns</p>\n</div>"
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df[\"prodrug\"]==1].drop_duplicates(\"inchi_key\")"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "outputs": [],
   "source": [
    "df = pd.read_csv(\"data/final_tables/mce_library_none.tsv\", sep=\"\\t\")\n",
    "df[\"CAS No.\"]=df[\"CAS No.\"].astype(str)\n"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "outputs": [
    {
     "data": {
      "text/plain": "Cat. No.                              object\nProduct Name                          object\nsynonyms                              object\nCAS No.                               object\nSmiles                                object\n                                      ...   \ndrugbank_approved_number             float64\ndrugcentral_administration_number    float64\nany_phase                               bool\nnone                                   int64\nlib_plate_well_unique                 object\nLength: 97, dtype: object"
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dtypes"
   ],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false,
    "pycharm": {
     "name": "#%%\n"
    }
   }
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}